{
  "data": {
    "entContent": {
      "approvedOn": "2024-04-22T15:42:55.213Z",
      "description": "\n          ",
      "doi": {
        "authors": [
          {
            "affiliations": [
              {
                "name": "National Institutes of Health (NIH)"
              }
            ],
            "person_or_org": {
              "name": "The Clinical Genome Resource (ClinGen)",
              "type": "organizational"
            },
            "role": {
              "id": "rightsholder"
            }
          },
          {
            "affiliations": [
              {
                "name": "The Clinical Genome Resource (ClinGen)"
              }
            ],
            "person_or_org": {
              "name": "Cardiomyopathy Variant Curation Expert Panel",
              "type": "organizational"
            },
            "role": {
              "id": "researchgroup"
            }
          }
        ],
        "conceptDoi": "10.5281/zenodo.21139259",
        "docDoi": "10.5281/zenodo.21139263",
        "keywords": [
          {
            "subject": "human"
          },
          {
            "subject": "biology"
          },
          {
            "subject": "genomics"
          },
          {
            "subject": "variant"
          },
          {
            "subject": "variant classification"
          },
          {
            "subject": "clingen"
          },
          {
            "subject": "disease"
          },
          {
            "subject": "standards"
          },
          {
            "subject": "MYH7"
          },
          {
            "subject": "Autosomal dominant inheritance"
          },
          {
            "subject": "dilated cardiomyopathy"
          },
          {
            "subject": "Autosomal dominant inheritance"
          },
          {
            "subject": "hypertrophic cardiomyopathy"
          }
        ]
      },
      "namespace": "GN002",
      "notes": "",
      "references": [
        {
          "source": "PubMed",
          "url": "https://pubmed.ncbi.nlm.nih.gov/29300372"
        }
      ],
      "releaseNotes": "Updated ClinGen Cardiomyopathy Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for MYH7",
      "releasedUnderRevision": true,
      "shortTitle": "MYH7-associated inherited cardiomyopathies - adapted from ACMG/AMP",
      "specificationSource": "",
      "states": [
        {
          "current": true,
          "event": {
            "name": "cspec-released",
            "prevState": "Approved For Release",
            "timeStamp": "2024-04-22T15:42:55.213Z"
          },
          "name": "Released"
        },
        {
          "current": false,
          "event": {
            "name": "cspec-reopened",
            "prevState": "Released",
            "timeStamp": "2022-12-02T21:18:52.580Z"
          },
          "name": "Pilot Rules In Prep"
        },
        {
          "current": false,
          "event": {
            "name": "pilot-rules-submitted",
            "prevState": "Pilot Rules In Prep",
            "timeStamp": "2024-03-25T21:14:13.513Z"
          },
          "name": "Pilot Rules Submitted"
        },
        {
          "current": false,
          "event": {
            "name": "pilot-rules-reviewed",
            "prevState": "Pilot Rules Submitted",
            "timeStamp": "2024-02-05T15:43:53.213Z"
          },
          "name": "Pilot Rules In Prep"
        },
        {
          "current": false,
          "event": {
            "name": "pilot-rules-approved",
            "prevState": "Pilot Rules Submitted",
            "timeStamp": "2024-03-27T16:44:47.105Z"
          },
          "name": "Approved For Release"
        }
      ],
      "tagNameSpaces": [
        "002"
      ],
      "title": "ClinGen Cardiomyopathy Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for MYH7 Version 2.0",
      "version": "2.0",
      "versioned": true
    },
    "entId": "GN002",
    "entType": "SequenceVariantInterpretation",
    "ld": {
      "Assertion": [
        {
          "entContent": {
            "curationActivity": "Variant Pathogenicity",
            "label": "Likely Pathogenic",
            "sepioId": "LN:LA26332-9"
          },
          "entType": "Assertion",
          "ldhId": "135642237",
          "ldhIri": "https://cspec.genome.network/cspec/Assertion/id/135642237",
          "modified": null,
          "rev": "_inf5Alm--B"
        },
        {
          "entContent": {
            "curationActivity": "Variant Pathogenicity",
            "label": "Benign",
            "sepioId": "LN:LA6675-8"
          },
          "entType": "Assertion",
          "ldhId": "135642236",
          "ldhIri": "https://cspec.genome.network/cspec/Assertion/id/135642236",
          "modified": null,
          "rev": "_inf5Alm--A"
        },
        {
          "entContent": {
            "curationActivity": "Variant Pathogenicity",
            "label": "Uncertain Significance - Insufficient Evidence",
            "sepioId": "LN:LA26333-7"
          },
          "entType": "Assertion",
          "ldhId": "135642235",
          "ldhIri": "https://cspec.genome.network/cspec/Assertion/id/135642235",
          "modified": null,
          "rev": "_inf5Ale--_"
        },
        {
          "entContent": {
            "curationActivity": "Variant Pathogenicity",
            "label": "Pathogenic",
            "sepioId": "LN:LA6668-3"
          },
          "entType": "Assertion",
          "ldhId": "135642233",
          "ldhIri": "https://cspec.genome.network/cspec/Assertion/id/135642233",
          "modified": null,
          "rev": "_inf5Alm--_"
        },
        {
          "entContent": {
            "curationActivity": "Variant Pathogenicity",
            "label": "Uncertain Significance - Conflicting Evidence",
            "sepioId": "LN:LA26333-7"
          },
          "entType": "Assertion",
          "ldhId": "135642231",
          "ldhIri": "https://cspec.genome.network/cspec/Assertion/id/135642231",
          "modified": null,
          "rev": "_inf5Ale--_"
        },
        {
          "entContent": {
            "curationActivity": "Variant Pathogenicity",
            "label": "Likely Benign",
            "sepioId": "LN:LA26334-5"
          },
          "entType": "Assertion",
          "ldhId": "135642232",
          "ldhIri": "https://cspec.genome.network/cspec/Assertion/id/135642232",
          "modified": null,
          "rev": "_inf5Ale---"
        },
        {
          "entContent": {
            "curationActivity": "Variant Pathogenicity",
            "label": "Uncertain Significance",
            "sepioId": "LN:LA26333-7"
          },
          "entType": "Assertion",
          "ldhId": "135642234",
          "ldhIri": "https://cspec.genome.network/cspec/Assertion/id/135642234",
          "modified": null,
          "rev": "_inf5Ale--A"
        }
      ],
      "CriteriaCode": [
        {
          "entContent": {
            "_uniqueProp": "002_BP6_nuclear_MYH7",
            "additionalComments": "This criterion is not for use as recommended by the ClinGen Sequence Variant Interpretation VCEP Review Committee.",
            "applicability": "Not Applicable for this VCEP",
            "baseStrength": "Benign",
            "defaultStrength": "Benign Supporting",
            "evidenceCategory": "Other Database",
            "gene": [
              "MYH7"
            ],
            "geneType": "nuclear",
            "instructionsToUse": "",
            "label": "BP6",
            "ns": "002",
            "originalACMGSummary": "Reputable source recently reports variant as benign, but the evidence is not available to the laboratory to perform an independent evaluation.",
            "references": [
              {
                "id": "29543229",
                "source": "PubMed",
                "url": "https://pubmed.ncbi.nlm.nih.gov/29543229"
              }
            ],
            "sepioID": "SEPIO-CG:99048",
            "strengthDescriptor": [
              {
                "applicability": "Not applicable",
                "instructionsToUse": "",
                "strength": "Stand Alone",
                "strengthSepioID": "SEPIO:0000325",
                "text": "This criterion is not for use as recommended by the ClinGen Sequence Variant Interpretation VCEP Review Committee.",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Not applicable",
                "instructionsToUse": "",
                "strength": "Very Strong",
                "strengthSepioID": "",
                "text": "This criterion is not for use as recommended by the ClinGen Sequence Variant Interpretation VCEP Review Committee.",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Not applicable",
                "instructionsToUse": "",
                "strength": "Strong",
                "strengthSepioID": "SEPIO:0000328",
                "text": "This criterion is not for use as recommended by the ClinGen Sequence Variant Interpretation VCEP Review Committee.",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Not applicable",
                "instructionsToUse": "",
                "strength": "Supporting",
                "strengthSepioID": "SEPIO:0000327",
                "text": "This criterion is not for use as recommended by the ClinGen Sequence Variant Interpretation VCEP Review Committee.",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Not applicable",
                "instructionsToUse": "",
                "strength": "Moderate",
                "strengthSepioID": "SEPIO:0000326",
                "text": "This criterion is not for use as recommended by the ClinGen Sequence Variant Interpretation VCEP Review Committee.",
                "type": "EvidenceLineStrength"
              }
            ]
          },
          "entType": "CriteriaCode",
          "ldhId": "638432779",
          "ldhIri": "https://cspec.genome.network/cspec/CriteriaCode/id/638432779",
          "modified": "2024-04-22T15:42:56.196Z",
          "modifier": "makelly2",
          "rev": "_inf5Aq---H"
        },
        {
          "entContent": {
            "_uniqueProp": "002_BP7_nuclear_MYH7",
            "additionalComments": "",
            "applicability": "Applicable",
            "baseStrength": "Benign",
            "defaultStrength": "Benign Supporting",
            "disease": [
              "MONDO:0004994",
              "MONDO:0005021",
              "MONDO:0005045",
              "MONDO:0005201",
              "MONDO:0009144"
            ],
            "evidenceCategory": "Computational And Predictive Data",
            "gene": [
              "MYH7"
            ],
            "geneType": "nuclear",
            "label": "BP7",
            "ns": "002",
            "originalACMGSummary": "A synonymous variant for which splicing prediction algorithms predict no impact to the splice consensus sequence nor the creation of a new splice site AND the nucleotide is not highly conserved.",
            "sepioID": "SEPIO-CG:99049",
            "specificationType": [],
            "status": {
              "Pilot Rules In Prep": {
                "completed": true
              }
            },
            "strengthDescriptor": [
              {
                "applicability": "Not applicable",
                "id": "0221",
                "instructionsToUse": "",
                "status": "not approved",
                "strength": "Stand Alone",
                "strengthSepioID": "SEPIO:0000325",
                "text": "",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Not applicable",
                "id": "0219",
                "instructionsToUse": "",
                "status": "not approved",
                "strength": "Very Strong",
                "strengthSepioID": "",
                "text": "",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Not Applicable",
                "id": "0065",
                "instructionsToUse": "",
                "status": "not approved",
                "strength": "Strong",
                "strengthSepioID": "SEPIO:0000328",
                "text": "",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Not Applicable",
                "id": "0220",
                "instructionsToUse": "",
                "status": "not approved",
                "strength": "Moderate",
                "strengthSepioID": "SEPIO:0000699",
                "text": "",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Applicable",
                "id": "117",
                "instructionsToUse": "",
                "specificationType": [
                  "General recommendation"
                ],
                "status": "approved",
                "strength": "Supporting",
                "strengthSepioID": "SEPIO:0000327",
                "text": "Also applicable to **intronic variants outside the splice consensus sequence (-4 and +7 outward)** for which splicing prediction algorithms predict no impact to the splice consensus sequence NOR the creation of a new splice site AND the nucleotide is not highly conserved.\n\nRule can be combined with BP4 to make a variant likely benign per Richards _et al._ 2015[<sup>1</sup>](#pmid_25741868).",
                "type": "EvidenceLineStrength"
              }
            ]
          },
          "entType": "CriteriaCode",
          "ldhId": "135637794",
          "ldhIri": "https://cspec.genome.network/cspec/CriteriaCode/id/135637794",
          "modified": "2024-04-22T15:42:56.196Z",
          "modifier": "makelly2",
          "rev": "_inf5AqW--T"
        },
        {
          "entContent": {
            "_uniqueProp": "002_PP3_nuclear_MYH7",
            "additionalComments": "",
            "applicability": "Applicable",
            "baseStrength": "Pathogenic",
            "defaultStrength": "Pathogenic Supporting",
            "disease": [
              "MONDO:0004994",
              "MONDO:0005021",
              "MONDO:0005045",
              "MONDO:0005201",
              "MONDO:0009144"
            ],
            "evidenceCategory": "Computational And Predictive Data",
            "gene": [
              "MYH7"
            ],
            "geneType": "nuclear",
            "label": "PP3",
            "ns": "002",
            "originalACMGSummary": "Multiple lines of computational evidence support a deleterious effect on the gene or gene product (conservation, evolutionary, splicing impact, etc.).\nCaveat: As many in silico algorithms use the same or very similar input for their predictions, each algorithm should not be counted as an independent criterion. PP3 can be used only once in any evaluation of a variant.",
            "sepioID": "SEPIO-CG:99035",
            "specificationType": [],
            "status": {
              "Pilot Rules In Prep": {
                "completed": true
              }
            },
            "strengthDescriptor": [
              {
                "applicability": "Not applicable",
                "id": "0238",
                "instructionsToUse": "",
                "status": "not approved",
                "strength": "Stand Alone",
                "strengthSepioID": "",
                "text": "",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Not applicable",
                "id": "0024",
                "instructionsToUse": "",
                "status": "not approved",
                "strength": "Very Strong",
                "strengthSepioID": "SEPIO:0000220",
                "text": "",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Not Applicable",
                "id": "0019",
                "instructionsToUse": "",
                "status": "not approved",
                "strength": "Strong",
                "strengthSepioID": "SEPIO:0000330",
                "text": "",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Not Applicable",
                "id": "0025",
                "instructionsToUse": "",
                "status": "not approved",
                "strength": "Moderate",
                "strengthSepioID": "SEPIO:0000216",
                "text": "",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Applicable",
                "id": "100",
                "instructionsToUse": "",
                "specificationType": [
                  "Disease-specific"
                ],
                "status": "approved",
                "strength": "Supporting",
                "strengthSepioID": "SEPIO:0000329",
                "text": "As many _in silico_ algorithms use the same or very similar input for their predictions, each algorithm should not be counted as an independent criterion. Meta-predictors, such as REVEL, are preferred over multiple individual predictors.\n\nUse of REVEL (Ioannidis _et al._ 2016[<sup>14</sup>](#pmid_27666373)) is recommended at thresholds of **≥0.70 for PP3**.\n\nClinical judgment is needed if any individual algorithms or conservation data are contradictory to REVEL data.\n\nPositive predictive value for benign/no impact predictions is generally higher than for pathogenic/impact predictions.\n\n[SpliceAI](https://spliceailookup.broadinstitute.org)[<sup>13</sup>](#pmid_30661751) is recommended for evaluation of predicted splice impacts.",
                "type": "EvidenceLineStrength"
              }
            ]
          },
          "entType": "CriteriaCode",
          "ldhId": "135637793",
          "ldhIri": "https://cspec.genome.network/cspec/CriteriaCode/id/135637793",
          "modified": "2024-04-22T15:42:56.196Z",
          "modifier": "makelly2",
          "rev": "_inf5AqW--Y"
        },
        {
          "entContent": {
            "_uniqueProp": "002_BA1_nuclear_MYH7",
            "additionalComments": "",
            "applicability": "Applicable",
            "baseStrength": "Benign",
            "defaultStrength": "Benign Stand Alone",
            "disease": [
              "MONDO:0004994",
              "MONDO:0005021",
              "MONDO:0005045",
              "MONDO:0005201",
              "MONDO:0009144"
            ],
            "evidenceCategory": "Population Data",
            "gene": [
              "MYH7"
            ],
            "geneType": "nuclear",
            "label": "BA1",
            "ns": "002",
            "originalACMGSummary": "Allele frequency is above 5% in Exome Sequencing Project, 1000 Genomes or Exome Aggregation Consortium.",
            "sepioID": "SEPIO-CG:99038",
            "specificationType": [],
            "status": {
              "Pilot Rules In Prep": {
                "completed": true
              }
            },
            "strengthDescriptor": [
              {
                "applicability": "Applicable",
                "id": "102",
                "instructionsToUse": "",
                "specificationType": [
                  "Disease-specific"
                ],
                "status": "approved",
                "strength": "Stand Alone",
                "strengthSepioID": "SEPIO:0000325",
                "text": "Allele frequency is **≥0.001** based on the **filtering allele frequency (FAF)** in **gnomAD** in the subpopulation with the highest frequency (popmax).\n\nThe values used to calculate the BA1 threshold were derived from studies in Northern European populations that have been relatively well-characterized with regards to disease prevalence and variant spectrum. These thresholds can be applied to any population where disease prevalence is considered comparable (1/300 or lower).\n\nThe threshold is applicable when assessing variants in the context of autosomal dominant cardiomyopathy. \n\ngnomAD is the preferred database for this calculation. If a subpopulation specific FAF other than the popmax is needed, this value can be calculated using the AlleleFrequencyApp on the [CardioDB website](https://cardiodb.org/allelefrequencyapp/).\n\n1.  Using the Inverse AF tab, enter in the population size and the number of alleles identified and it will calculate the FAF.  \n2.  Set confidence to 0.95 (95%).\n3.  If the FAF is ≥0.001, this rule can be applied.\n\nThe FAF by platform (e.g., exome vs. genome; v.2.1.1 vs. v.3.1.1) should be considered, the larger population is most likely to have the most accurate representation of “true” population allele frequency.\n\nCaution is needed when considering any population cohorts that are smaller than the smallest subpopulations within gnomAD v.2.1.1 (e.g., ~5000 individuals or ~10,000 alleles). Despite this conservative nature of this threshold and approach, in smaller cohorts, the observed allele frequency may less accurately reflect the true allele frequency. Traditionally, once a variant is classified as Benign, it is rarely re-evaluated and so the highest confidence is needed to establish that classification on an allele frequency alone.",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Not applicable",
                "id": "0201",
                "instructionsToUse": "",
                "status": "not approved",
                "strength": "Very Strong",
                "strengthSepioID": "",
                "text": "",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Not applicable",
                "id": "0202",
                "instructionsToUse": "",
                "status": "not approved",
                "strength": "Strong",
                "strengthSepioID": "SEPIO:0000328",
                "text": "",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Not applicable",
                "id": "0203",
                "instructionsToUse": "",
                "status": "not approved",
                "strength": "Moderate",
                "strengthSepioID": "SEPIO:0000699",
                "text": "",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Not applicable",
                "id": "0089",
                "instructionsToUse": "",
                "status": "not approved",
                "strength": "Supporting",
                "strengthSepioID": "SEPIO:0000327",
                "text": "",
                "type": "EvidenceLineStrength"
              }
            ]
          },
          "entType": "CriteriaCode",
          "ldhId": "135637791",
          "ldhIri": "https://cspec.genome.network/cspec/CriteriaCode/id/135637791",
          "modified": "2024-04-22T15:42:56.196Z",
          "modifier": "makelly2",
          "rev": "_inf5Aq---F"
        },
        {
          "entContent": {
            "_uniqueProp": "002_PS4_nuclear_MYH7",
            "additionalComments": "",
            "applicability": "Applicable",
            "baseStrength": "Pathogenic",
            "defaultStrength": "Pathogenic Strong",
            "disease": [
              "MONDO:0004994",
              "MONDO:0005021",
              "MONDO:0005045",
              "MONDO:0005201",
              "MONDO:0009144"
            ],
            "evidenceCategory": "Population Data",
            "gene": [
              "MYH7"
            ],
            "geneType": "nuclear",
            "label": "PS4",
            "ns": "002",
            "originalACMGSummary": "The prevalence of the variant in affected individuals is significantly increased compared to the prevalence in controls.\nNote 1: Relative risk (RR) or odds ratio (OR), as obtained from case-control studies, is >5.0 and the confidence interval around the estimate of RR or OR does not include 1.0. See manuscript for detailed guidance.\nNote 2: In instances of very rare variants where case-control studies may not reach statistical significance, the prior observation of the variant in multiple unrelated patients with the same phenotype, and its absence in controls, may be used as moderate level of evidence.",
            "sepioID": "SEPIO-CG:99026",
            "specificationType": [],
            "status": {
              "Pilot Rules In Prep": {
                "completed": true
              }
            },
            "strengthDescriptor": [
              {
                "applicability": "Not applicable",
                "id": "0243",
                "instructionsToUse": "",
                "status": "not approved",
                "strength": "Stand Alone",
                "strengthSepioID": "",
                "text": "",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Not Applicable",
                "id": "0029",
                "instructionsToUse": "",
                "status": "not approved",
                "strength": "Very Strong",
                "strengthSepioID": "SEPIO:0000220",
                "text": "",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Applicable",
                "id": "111",
                "instructionsToUse": "",
                "specificationType": [
                  "Disease-specific"
                ],
                "status": "approved",
                "strength": "Strong",
                "strengthSepioID": "SEPIO:0000330",
                "text": "Currently few well-designed case-control studies have been performed for inherited cardiomyopathies.  Until such studies become available, comparative analyses can be undertaken using case data (e.g., internal and/or published cohorts) and control data from population-level cohorts (e.g., gnomAD). \n\nCohorts used in these analyses should meet the following criteria: \n\n1.  The cases have a clinical diagnosis of the specified disorder or related phenotype (e.g., all cases have HCM or another relevant phenotype\\*). \n    *   When assessing cases, it's important to consider how likely another potential cause of the phenotype has been excluded.  This includes considering the presence of other variants in relevant genes (particularly those likely to be contributing to phenotype) and the extent of testing performed (i.e., single gene sequencing, panel testing, whole exome/genome sequencing).\n2.  The controls should not be derived from study populations that might be enriched for the specified disorder.\n3.  The denominator of the cohorts must be available (e.g., variant detected in 5 out of 3,500 cases and 1 out of 60,000 controls).\n4.  The cohorts do not include closely related individuals (i.e., family members are not included in the case counts).\n5.  The cohorts do not overlap with other cohorts being used in the analysis (i.e., cases are not being counted more than once).\n6.  The population diversity of the case and control cohorts are broadly similar.\n7.  Consider the size of the case cohort — larger cohorts are likely to provide more accurate estimates of variant frequency; therefore, it may be preferable to use data from the largest available case series for case-control analyses (e.g., Walsh _et al._ 2017[<sup>8</sup>](#pmid_27532257), [DECIPHER](https://www.deciphergenomics.org/gene/MYH7/patient-overlap/snvs)).\n\nTo account for limitations that arise when performing unmatched case-control analyses, the following stringent OR threshold is recommended:\n\n*   **STRONG** evidence requires the lower bound of the 95% confidence interval (CI) around the odds ratio (OR) estimate to be **≥20**\n\nA PS4 calculator is available at [www.cardiodb.org](https://www.cardiodb.org/ps4_calculator/ps4_calculator.html).\n\nIf multiple cohorts are available, the final ORs and associated CIs need to be harmonized across all cohorts to determine the final level (e.g., if 2 large cohorts have an OR of ~6 and a third small cohort has an OR of 11, application at a SUPPORTING level should be considered).  \n\n**\\*RELEVANT PHENOTYPES:**\n\n1.  Cases of HCM and RCM may be combined as they are considered part of the same disease spectrum. \n2.  For the eight genes covered by these guidelines, the combination of probands with other phenotypes should be reviewed by a clinical expert to determine if grouping is appropriate. \n3.  Additional considerations for LVNC and end-stage HCM: \n    *   Due to the current debate about whether isolated LVNC represents a true disease entity or variation of typical cardiac morphology (Anderson _et al._ 2017[<sup>9</sup>](#pmid_28395867); Oechslin _et al._ 2017[<sup>6</sup>](#pmid_28545618); Hershberger _et al._ 2017[<sup>5</sup>](#pmid_29212902); Ross _et al._ 2020[<sup>7</sup>](#pmid_31143950)), individuals with isolated LVNC should NOT be added to proband or segregation counts (including individuals with isolated LVNC in a family with other cardiomyopathies).\n\nHCM and DCM have distinct mechanisms of disease and therefore pathogenetic variants are not anticipated to cause both primary phenotypes. While occurrence in both phenotypes may initially be considered as evidence against pathogenicity, end-stage HCM can present similarly to DCM. Careful consideration is needed before including DCM or related phenotypes in case or segregation data for primarily HCM variants.",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Applicable",
                "id": "123",
                "instructionsToUse": "",
                "specificationType": [
                  "Disease-specific"
                ],
                "status": "approved",
                "strength": "Moderate",
                "strengthSepioID": "SEPIO:0000216",
                "text": "Currently few well-designed case-control studies have been performed for inherited cardiomyopathies.  Until such studies become available, comparative analyses can be undertaken using case data (e.g., internal and/or published cohorts) and control data from population-level cohorts (e.g., gnomAD). \n\nCohorts used in these analyses should meet the following criteria: \n\n1.  The cases have a clinical diagnosis of the specified disorder or related phenotype (e.g., all cases have HCM or another relevant phenotype\\*). \n    *   When assessing cases, it's important to consider how likely another potential cause of the phenotype has been excluded.  This includes considering the presence of other variants in relevant genes (particularly those likely to be contributing to phenotype) and the extent of testing performed (i.e., single gene sequencing, panel testing, whole exome/genome sequencing).\n2.  The controls should not be derived from study populations that might be enriched for the specified disorder.\n3.  The denominator of the cohorts must be available (e.g., variant detected in 5 out of 3,500 cases and 1 out of 60,000 controls).\n4.  The cohorts do not include closely related individuals (i.e., family members are not included in the case counts).\n5.  The cohorts do not overlap with other cohorts being used in the analysis (i.e., cases are not being counted more than once).\n6.  The population diversity of the case and control cohorts are broadly similar.\n7.  Consider the size of the case cohort — larger cohorts are likely to provide more accurate estimates of variant frequency; therefore, it may be preferable to use data from the largest available case series for case-control analyses (e.g., Walsh _et al._ 2017[<sup>8</sup>](#pmid_27532257), [DECIPHER](https://www.deciphergenomics.org/gene/MYH7/patient-overlap/snvs)).\n\nTo account for limitations that arise when performing unmatched case-control analyses, the following stringent OR threshold is recommended:\n\n*   **MODERATE** evidence requires the lower bound of the 95% CI around the OR to be **≥10**\n\nA PS4 calculator is available at [www.cardiodb.org](https://www.cardiodb.org/ps4_calculator/ps4_calculator.html).\n\nIf multiple cohorts are available, the final ORs and associated CIs need to be harmonized across all cohorts to determine the final level (e.g., if 2 large cohorts have an OR of ~6 and a third small cohort has an OR of 11, application at a SUPPORTING level should be considered).  \n\n**\\*RELEVANT PHENOTYPES:**\n\n1.  Cases of HCM and RCM may be combined as they are considered part of the same disease spectrum. \n2.  For the eight genes covered by these guidelines, the combination of probands with other phenotypes should be reviewed by a clinical expert to determine if grouping is appropriate. \n3.  Additional considerations for LVNC and end-stage HCM: \n    *   Due to the current debate about whether isolated LVNC represents a true disease entity or variation of typical cardiac morphology (Anderson _et al._ 2017[<sup>9</sup>](#pmid_28395867); Oechslin _et al._ 2017[<sup>6</sup>](#pmid_28545618); Hershberger _et al._ 2017[<sup>5</sup>](#pmid_29212902); Ross _et al._ 2020[<sup>7</sup>](#pmid_31143950)), individuals with isolated LVNC should NOT be added to proband or segregation counts (including individuals with isolated LVNC in a family with other cardiomyopathies).\n\nHCM and DCM have distinct mechanisms of disease and therefore pathogenetic variants are not anticipated to cause both primary phenotypes. While occurrence in both phenotypes may initially be considered as evidence against pathogenicity, end-stage HCM can present similarly to DCM. Careful consideration is needed before including DCM or related phenotypes in case or segregation data for primarily HCM variants.",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Applicable",
                "id": "115",
                "instructionsToUse": "",
                "specificationType": [
                  "Disease-specific"
                ],
                "status": "approved",
                "strength": "Supporting",
                "strengthSepioID": "SEPIO:0000329",
                "text": "Currently few well-designed case-control studies have been performed for inherited cardiomyopathies.  Until such studies become available, comparative analyses can be undertaken using case data (e.g., internal and/or published cohorts) and control data from population-level cohorts (e.g., gnomAD). \n\nCohorts used in these analyses should meet the following criteria: \n\n1.  The cases have a clinical diagnosis of the specified disorder or related phenotype (e.g., all cases have HCM or another relevant phenotype\\*). \n    *   When assessing cases, it's important to consider how likely another potential cause of the phenotype has been excluded.  This includes considering the presence of other variants in relevant genes (particularly those likely to be contributing to phenotype) and the extent of testing performed (i.e., single gene sequencing, panel testing, whole exome/genome sequencing).\n2.  The controls should not be derived from study populations that might be enriched for the specified disorder.\n3.  The denominator of the cohorts must be available (e.g., variant detected in 5 out of 3,500 cases and 1 out of 60,000 controls).\n4.  The cohorts do not include closely related individuals (i.e., family members are not included in the case counts).\n5.  The cohorts do not overlap with other cohorts being used in the analysis (i.e., cases are not being counted more than once).\n6.  The population diversity of the case and control cohorts are broadly similar.\n7.  Consider the size of the case cohort — larger cohorts are likely to provide more accurate estimates of variant frequency; therefore, it may be preferable to use data from the largest available case series for case-control analyses (e.g., Walsh _et al._ 2017[<sup>8</sup>](#pmid_27532257), [DECIPHER](https://www.deciphergenomics.org/gene/MYH7/patient-overlap/snvs)).\n\nTo account for limitations that arise when performing unmatched case-control analyses, the following stringent OR threshold is recommended:\n\n*   **SUPPORTING** evidence requires the lower bound of the 95% CI around the OR to be **≥5**\n\nA PS4 calculator is available at [www.cardiodb.org](https://www.cardiodb.org/ps4_calculator/ps4_calculator.html).\n\nIf multiple cohorts are available, the final ORs and associated CIs need to be harmonized across all cohorts to determine the final level (e.g., if 2 large cohorts have an OR of ~6 and a third small cohort has an OR of 11, application at a SUPPORTING level should be considered).  \n\n**\\*RELEVANT PHENOTYPES:**\n\n1.  Cases of HCM and RCM may be combined as they are considered part of the same disease spectrum. \n2.  For the eight genes covered by these guidelines, the combination of probands with other phenotypes should be reviewed by a clinical expert to determine if grouping is appropriate. \n3.  Additional considerations for LVNC and end-stage HCM: \n    *   Due to the current debate about whether isolated LVNC represents a true disease entity or variation of typical cardiac morphology (Anderson _et al._ 2017[<sup>9</sup>](#pmid_28395867); Oechslin _et al._ 2017[<sup>6</sup>](#pmid_28545618); Hershberger _et al._ 2017[<sup>5</sup>](#pmid_29212902); Ross _et al._ 2020[<sup>7</sup>](#pmid_31143950)), individuals with isolated LVNC should NOT be added to proband or segregation counts (including individuals with isolated LVNC in a family with other cardiomyopathies).\n\nHCM and DCM have distinct mechanisms of disease and therefore pathogenetic variants are not anticipated to cause both primary phenotypes. While occurrence in both phenotypes may initially be considered as evidence against pathogenicity, end-stage HCM can present similarly to DCM. Careful consideration is needed before including DCM or related phenotypes in case or segregation data for primarily HCM variants.",
                "type": "EvidenceLineStrength"
              }
            ]
          },
          "entType": "CriteriaCode",
          "ldhId": "135637788",
          "ldhIri": "https://cspec.genome.network/cspec/CriteriaCode/id/135637788",
          "modified": "2024-04-22T15:42:56.196Z",
          "modifier": "makelly2",
          "rev": "_inf5AqS--G"
        },
        {
          "entContent": {
            "_uniqueProp": "002_PS3_nuclear_MYH7",
            "additionalComments": "",
            "applicability": "Applicable",
            "baseStrength": "Pathogenic",
            "defaultStrength": "Pathogenic Strong",
            "disease": [
              "MONDO:0004994",
              "MONDO:0005021",
              "MONDO:0005045",
              "MONDO:0005201",
              "MONDO:0009144"
            ],
            "evidenceCategory": "Functional Data",
            "gene": [
              "MYH7"
            ],
            "geneType": "nuclear",
            "instructionsToUse": "Evaluation of studies/assays is required prior to application of functional evidence at any strength.\n\nRefer to SVI guidance for functional evidence (Brnich _et al._ 2020[<sup>4</sup>](#pmid_31892348)).\n\nIn the context of cardiomyopathy, very few functional assays currently meet criteria sufficient for application of this rule at a STRONG level. Examples of the types of study/assays that MAY be relevant are described, but further definition of cardiomyopathy models/assays is outside the scope of these guidelines.",
            "label": "PS3",
            "ns": "002",
            "originalACMGSummary": "Well-established in vitro or in vivo functional studies supportive of a damaging effect on the gene or gene product.\nNote: Functional studies that have been validated and shown to be reproducible and robust in a clinical diagnostic laboratory setting are considered the most well-established.",
            "sepioID": "SEPIO-CG:99025",
            "specificationType": [],
            "status": {
              "Pilot Rules In Prep": {
                "completed": true
              }
            },
            "strengthDescriptor": [
              {
                "applicability": "Not applicable",
                "id": "0242",
                "instructionsToUse": "",
                "status": "not approved",
                "strength": "Stand Alone",
                "strengthSepioID": "",
                "text": "",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Not Applicable",
                "id": "0031",
                "instructionsToUse": "",
                "status": "not approved",
                "strength": "Very Strong",
                "strengthSepioID": "SEPIO:0000220",
                "text": "",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Applicable",
                "id": "109",
                "instructionsToUse": "",
                "specificationType": [
                  "Disease-specific"
                ],
                "status": "approved",
                "strength": "Strong",
                "strengthSepioID": "SEPIO:0000330",
                "text": "**In vitro splicing assays (e.g., RNA studies)**\n\n_In vitro_ splicing assays may be considered as **STRONG** evidence, providing the following criteria are met.\n\n*   Prior knowledge of predominant transcripts in cardiac tissue\n\nAnalysis undertaken using RNA extracted from cardiac tissue from the individual with the variant\n\nAnalysis undertaken using RNA extracted from whole blood providing the relevant transcripts (isoforms) are expressed in blood and are at sufficient levels to assess splice disruption.\n\nAssay shows a clear, reproducible and convincing effect on splicing (i.e. a distinct splice product, present at a level comparable to the splice product from the wild-type allele), which is not observed in controls\n\n*   Confirmation of abnormal splice product by Sanger sequencing\n\n**NOTE:** Mini-gene assay in non-patient derived cell lines are NOT considered to provide STRONG evidence.\n\n**NOTE:**  Whether to activate this rule needs to be reconciled with the variant spectrum and disease mechanism for the gene at hand (i.e., consider whether the effect is likely to lead to LOF or an in-frame alteration and whether this type of effect is expected to be disease causing) (Abou Tayoun _et al._ 2018[<sup>3</sup>](#pmid_30192042)).",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Applicable",
                "id": "0039",
                "instructionsToUse": "",
                "specificationType": [
                  "Disease-specific"
                ],
                "status": "not approved",
                "strength": "Moderate",
                "strengthSepioID": "SEPIO:0000216",
                "text": "**In vivo models (e.g., variant knock-in animal models)**\n\nMammalian variant-specific knock-in animal models that produce a phenotype consistent with the clinical phenotype in humans (e.g., structural and/or functional cardiac abnormalities, premature death, arrhythmia) may be considered as **MODERATE** evidence\n\n**NOTE:** The following assays/models do NOT meet criteria\n\n1.  Assays that are known to be associated with non-specific cardiac phenotypes (e.g., morpholino-induced pericardial edema in zebrafish)\n2.  In vivo evidence that is not variant specific, such as whole gene alterations (i.e., cDNA or whole gene transgenic mice and whole or partial gene knock-out mice)",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Applicable",
                "id": "0045",
                "instructionsToUse": "",
                "specificationType": [
                  "Disease-specific"
                ],
                "status": "not approved",
                "strength": "Supporting",
                "strengthSepioID": "SEPIO:0000329",
                "text": "_**In vitro**_ **assays (e.g., biochemical assays of myofilament function, motility assays, human iPSC-CM)**\n\nWhile some _in vitro_ assays may provide evidence that a variant in a cardiomyopathy gene has an effect on protein and/or myofilament function, at present, there are no validated “gold-standard” assays that are considered to reliably predict the clinical phenotype.\n\nAs such, in the cardiomyopathy genes listed in these guidelines, data from individual _in vitro_ studies are unlikely to meet the criteria required to assign this rule at more than SUPPORTING level.",
                "type": "EvidenceLineStrength"
              }
            ]
          },
          "entType": "CriteriaCode",
          "ldhId": "135637785",
          "ldhIri": "https://cspec.genome.network/cspec/CriteriaCode/id/135637785",
          "modified": "2024-04-22T15:42:56.196Z",
          "modifier": "makelly2",
          "rev": "_inf5AqG--j"
        },
        {
          "entContent": {
            "_uniqueProp": "002_PS2_nuclear_MYH7",
            "additionalComments": "",
            "applicability": "Applicable",
            "baseStrength": "Pathogenic",
            "defaultStrength": "Pathogenic Strong",
            "disease": [
              "MONDO:0004994",
              "MONDO:0005021",
              "MONDO:0005045",
              "MONDO:0005201",
              "MONDO:0009144"
            ],
            "evidenceCategory": "De novo Data",
            "gene": [
              "MYH7"
            ],
            "geneType": "nuclear",
            "label": "PS2",
            "ns": "002",
            "originalACMGSummary": "De novo (both maternity and paternity confirmed) in a patient with the disease and no family history.\nNote: Confirmation of paternity only is insufficient. Egg donation, surrogate motherhood, errors in embryo transfer, etc. can contribute to non-maternity.",
            "sepioID": "SEPIO-CG:99024",
            "specificationType": [],
            "status": {
              "Pilot Rules In Prep": {
                "completed": true
              }
            },
            "strengthDescriptor": [
              {
                "applicability": "Not applicable",
                "id": "0241",
                "instructionsToUse": "",
                "status": "not approved",
                "strength": "Stand Alone",
                "strengthSepioID": "",
                "text": "",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Not Applicable",
                "id": "0016",
                "instructionsToUse": "",
                "status": "not approved",
                "strength": "Very Strong",
                "strengthSepioID": "SEPIO:0000220",
                "text": "",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Applicable",
                "id": "112",
                "instructionsToUse": "",
                "specificationType": [
                  "Disease-specific"
                ],
                "status": "approved",
                "strength": "Strong",
                "strengthSepioID": "SEPIO:0000330",
                "text": "Refer to SVI guidance on number/combination of cases required based on phenotype specificity[<sup>2</sup>](#url_c73e109e-b916-5a72-b7b1-1762446f3c11)).\n\nFor most cardiomyopathies, it is recommended to default to **Phenotype consistency: “Phenotype consistent with gene but not highly specific”**. Clinical judgment is required for shifting to a higher or lower category. \n\nFor use as a STRONG or VERY STRONG criterion, ideally parents have been thoroughly clinically evaluated without evidence of cardiomyopathy (ideally using a combination of ECG and echocardiogram or cardiac MRI for maximum sensitivity).\n\nA family history consistent with _de novo_ inheritance should not have any clinical signs or symptoms suggestive of cardiomyopathy in a 1<sup>st</sup> or 2<sup>nd</sup> degree relative, for example: \n\n1.  Sudden death under 60 years of age\n2.  Heart transplant\n3.  Implantable cardiac defibrillator (ICD) under 60 years of age\n4.  Features of cardiomyopathy (e.g., systolic dysfunction, hypertrophy, left ventricular enlargement in an individual without risk factors).\n5.  Other related/overlapping cardiomyopathies\n\nExamples of non-suspicious family history may include non-specific clinical features (e.g., palpitations, syncope, borderline/inconclusive echocardiogram findings, heart attack if age appropriate and suspected to result from coronary artery disease), but every attempt should be made to clarify features. \n\nGenerally, this criterion is only applicable in the ABSENCE of any other possible disease-causing variants.  If other pathogenic or likely pathogenic variants are present, consider decreasing points assigned or overall weight.",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Not Applicable",
                "id": "004",
                "instructionsToUse": "",
                "status": "not approved",
                "strength": "Moderate",
                "strengthSepioID": "SEPIO:0000216",
                "text": "",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Not Applicable",
                "id": "0043",
                "instructionsToUse": "",
                "status": "not approved",
                "strength": "Supporting",
                "strengthSepioID": "SEPIO:0000329",
                "text": "",
                "type": "EvidenceLineStrength"
              }
            ]
          },
          "entType": "CriteriaCode",
          "ldhId": "135637783",
          "ldhIri": "https://cspec.genome.network/cspec/CriteriaCode/id/135637783",
          "modified": "2024-04-22T15:42:56.196Z",
          "modifier": "makelly2",
          "rev": "_inf5AqW--W"
        },
        {
          "entContent": {
            "_uniqueProp": "002_PM4_nuclear_MYH7",
            "additionalComments": "",
            "applicability": "Applicable",
            "baseStrength": "Pathogenic",
            "defaultStrength": "Pathogenic Moderate",
            "disease": [
              "MONDO:0004994",
              "MONDO:0005021",
              "MONDO:0005045",
              "MONDO:0005201",
              "MONDO:0009144"
            ],
            "evidenceCategory": "Computational And Predictive Data",
            "gene": [
              "MYH7"
            ],
            "geneType": "nuclear",
            "label": "PM4",
            "ns": "002",
            "originalACMGSummary": "Protein length changes due to in-frame deletions/insertions in a non-repeat region or stop-loss variants.",
            "sepioID": "SEPIO-CG:99030",
            "specificationType": [],
            "status": {
              "Pilot Rules In Prep": {
                "completed": true
              }
            },
            "strengthDescriptor": [
              {
                "applicability": "Not applicable",
                "id": "0233",
                "instructionsToUse": "",
                "status": "not approved",
                "strength": "Stand Alone",
                "strengthSepioID": "",
                "text": "",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Not applicable",
                "id": "0012",
                "instructionsToUse": "",
                "status": "not approved",
                "strength": "Very Strong",
                "strengthSepioID": "SEPIO:0000220",
                "text": "",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Not Applicable",
                "id": "0035",
                "instructionsToUse": "",
                "status": "not approved",
                "strength": "Strong",
                "strengthSepioID": "SEPIO:0000330",
                "text": "",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Applicable",
                "id": "108",
                "instructionsToUse": "",
                "specificationType": [
                  "Disease-specific"
                ],
                "status": "approved",
                "strength": "Moderate",
                "strengthSepioID": "SEPIO:0000216",
                "text": "Strength of rule should be carefully considered and may require downgrading to SUPPORTING based on the predicted impact of the variant, including the size of the deletion/insertion, its location, and conservation of the region. \n\nFor genes where PVS1 is not applicable (i.e., where there is no evidence that pLOF variants cause disease), consider using this rule at MODERATE or SUPPORTING strength for truncating variants that do NOT undergo nonsense mediated decay (NMD).",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Not Applicable",
                "id": "0059",
                "instructionsToUse": "",
                "status": "not approved",
                "strength": "Supporting",
                "strengthSepioID": "SEPIO:0000329",
                "text": "",
                "type": "EvidenceLineStrength"
              }
            ]
          },
          "entType": "CriteriaCode",
          "ldhId": "135637775",
          "ldhIri": "https://cspec.genome.network/cspec/CriteriaCode/id/135637775",
          "modified": "2024-04-22T15:42:56.196Z",
          "modifier": "makelly2",
          "rev": "_inf5Aq---G"
        },
        {
          "entContent": {
            "_uniqueProp": "002_PS1_nuclear_MYH7",
            "additionalComments": "",
            "applicability": "Applicable",
            "baseStrength": "Pathogenic",
            "defaultStrength": "Pathogenic Strong",
            "disease": [
              "MONDO:0004994",
              "MONDO:0005021",
              "MONDO:0005045",
              "MONDO:0005201",
              "MONDO:0009144"
            ],
            "evidenceCategory": "Computational And Predictive Data",
            "gene": [
              "MYH7"
            ],
            "geneType": "nuclear",
            "label": "PS1",
            "ns": "002",
            "originalACMGSummary": "Same amino acid change as a previously established pathogenic variant regardless of nucleotide change.\nExample: Val->Leu caused by either G>C or G>T in the same codon.\nCaveat: Beware of changes that impact splicing rather than at the amino acid/protein level.",
            "sepioID": "SEPIO-CG:99023",
            "specificationType": [],
            "status": {
              "Pilot Rules In Prep": {
                "completed": true
              }
            },
            "strengthDescriptor": [
              {
                "applicability": "Not applicable",
                "id": "0240",
                "instructionsToUse": "",
                "status": "not approved",
                "strength": "Stand Alone",
                "strengthSepioID": "",
                "text": "",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Not applicable",
                "id": "0021",
                "instructionsToUse": "",
                "status": "not approved",
                "strength": "Very Strong",
                "strengthSepioID": "SEPIO:0000220",
                "text": "",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Applicable",
                "id": "110",
                "instructionsToUse": "",
                "specificationType": [
                  "No change"
                ],
                "status": "approved",
                "strength": "Strong",
                "strengthSepioID": "SEPIO:0000330",
                "text": "No cardiomyopathy specifications. Apply as outlined by Richards _et al_. 2015[<sup>1</sup>](#pmid_25741868).\n\nExample of when rule should NOT be applied. NM\\_000256.3(_MYBPC3_): c.2308G>A (p.Asp770Asn) has an established impact on splicing leading to nonsense mediated decay (NMD) and should not be used to provide evidence for other variants observed to result in the same amino acid change.",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Not Applicable",
                "id": "0046",
                "instructionsToUse": "",
                "status": "not approved",
                "strength": "Moderate",
                "strengthSepioID": "SEPIO:0000216",
                "text": "",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Not Applicable",
                "id": "0036",
                "instructionsToUse": "",
                "status": "not approved",
                "strength": "Supporting",
                "strengthSepioID": "SEPIO:0000329",
                "text": "",
                "type": "EvidenceLineStrength"
              }
            ]
          },
          "entType": "CriteriaCode",
          "ldhId": "135637781",
          "ldhIri": "https://cspec.genome.network/cspec/CriteriaCode/id/135637781",
          "modified": "2024-04-22T15:42:56.196Z",
          "modifier": "makelly2",
          "rev": "_inf5AqW--V"
        },
        {
          "entContent": {
            "_uniqueProp": "002_BS3_nuclear_MYH7",
            "additionalComments": "",
            "applicability": "Applicable",
            "baseStrength": "Benign",
            "defaultStrength": "Benign Strong",
            "disease": [
              "MONDO:0004994",
              "MONDO:0005021",
              "MONDO:0005045",
              "MONDO:0005201",
              "MONDO:0009144"
            ],
            "evidenceCategory": "Functional Data",
            "gene": [
              "MYH7"
            ],
            "geneType": "nuclear",
            "instructionsToUse": "Evaluation of studies/assays is required prior to application of functional evidence at any strength.\n\nRefer to SVI guidance for functional evidence (Brnich _et al._ 2020[<sup>4</sup>](#pmid_31892348)).\n\nIn the context of cardiomyopathy, very few functional assays currently meet criteria sufficient for application of this rule at a STRONG level. Examples of the types of study/assays that MAY be relevant are described, but further definition of cardiomyopathy models/assays is outside the scope of these guidelines.",
            "label": "BS3",
            "ns": "002",
            "originalACMGSummary": "Well-established in vitro or in vivo functional studies show no damaging effect on protein function or splicing.",
            "sepioID": "SEPIO-CG:99041",
            "specificationType": [],
            "status": {
              "Pilot Rules In Prep": {
                "completed": true
              }
            },
            "strengthDescriptor": [
              {
                "applicability": "Not applicable",
                "id": "0226",
                "instructionsToUse": "",
                "status": "not approved",
                "strength": "Stand Alone",
                "strengthSepioID": "SEPIO:0000325",
                "text": "",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Not applicable",
                "id": "0225",
                "instructionsToUse": "",
                "status": "not approved",
                "strength": "Very Strong",
                "strengthSepioID": "",
                "text": "",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Applicable",
                "id": "122",
                "instructionsToUse": "",
                "specificationType": [
                  "No change"
                ],
                "status": "approved",
                "strength": "Strong",
                "strengthSepioID": "SEPIO:0000328",
                "text": "See PS3 specifications.",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Applicable",
                "id": "0100",
                "instructionsToUse": "",
                "specificationType": [
                  "Disease-specific"
                ],
                "status": "not approved",
                "strength": "Moderate",
                "strengthSepioID": "SEPIO:0001327",
                "text": "See PS3 specifications.",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Applicable",
                "id": "0085",
                "instructionsToUse": "",
                "specificationType": [
                  "Disease-specific"
                ],
                "status": "not approved",
                "strength": "Supporting",
                "strengthSepioID": "SEPIO:0000327",
                "text": "See PS3 specifications.",
                "type": "EvidenceLineStrength"
              }
            ]
          },
          "entType": "CriteriaCode",
          "ldhId": "135637776",
          "ldhIri": "https://cspec.genome.network/cspec/CriteriaCode/id/135637776",
          "modified": "2024-04-22T15:42:56.196Z",
          "modifier": "makelly2",
          "rev": "_inf5AqS--C"
        },
        {
          "entContent": {
            "_uniqueProp": "002_PP5_nuclear_MYH7",
            "additionalComments": "This criterion is not for use as recommended by the ClinGen Sequence Variant Interpretation VCEP Review Committee.",
            "applicability": "Not Applicable for this VCEP",
            "baseStrength": "Pathogenic",
            "defaultStrength": "Pathogenic Supporting",
            "evidenceCategory": "Other Database",
            "gene": [
              "MYH7"
            ],
            "geneType": "nuclear",
            "instructionsToUse": "",
            "label": "PP5",
            "ns": "002",
            "originalACMGSummary": "Reputable source recently reports variant as pathogenic, but the evidence is not available to the laboratory to perform an independent evaluation.",
            "references": [
              {
                "id": "29543229",
                "source": "PubMed",
                "url": "https://pubmed.ncbi.nlm.nih.gov/29543229"
              }
            ],
            "sepioID": "SEPIO-CG:99049",
            "strengthDescriptor": [
              {
                "applicability": "Not applicable",
                "instructionsToUse": "",
                "strength": "Stand Alone",
                "strengthSepioID": "",
                "text": "This criterion is not for use as recommended by the ClinGen Sequence Variant Interpretation VCEP Review Committee.",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Not applicable",
                "instructionsToUse": "",
                "strength": "Very Strong",
                "strengthSepioID": "SEPIO:0000220",
                "text": "This criterion is not for use as recommended by the ClinGen Sequence Variant Interpretation VCEP Review Committee.",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Not applicable",
                "instructionsToUse": "",
                "strength": "Strong",
                "strengthSepioID": "SEPIO:0000330",
                "text": "This criterion is not for use as recommended by the ClinGen Sequence Variant Interpretation VCEP Review Committee.",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Not applicable",
                "instructionsToUse": "",
                "strength": "Supporting",
                "strengthSepioID": "SEPIO:0000329",
                "text": "This criterion is not for use as recommended by the ClinGen Sequence Variant Interpretation VCEP Review Committee.",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Not applicable",
                "instructionsToUse": "",
                "strength": "Moderate",
                "strengthSepioID": "SEPIO:0000216",
                "text": "This criterion is not for use as recommended by the ClinGen Sequence Variant Interpretation VCEP Review Committee.",
                "type": "EvidenceLineStrength"
              }
            ]
          },
          "entType": "CriteriaCode",
          "ldhId": "638432780",
          "ldhIri": "https://cspec.genome.network/cspec/CriteriaCode/id/638432780",
          "modified": "2024-04-22T15:42:56.196Z",
          "modifier": "makelly2",
          "rev": "_inf5AqW--a"
        },
        {
          "entContent": {
            "_uniqueProp": "002_PP2_nuclear_MYH7",
            "additionalComments": "Application of this rule takes into consideration empirical data quantifying levels of rare missense variant enrichment in HCM referral cohorts compared to population-based cohorts (Walsh et al. 2019 PMID:30696458) rather than the missense constraint score in gnomAD. For MYH7, there is evidence for regional enrichment of rare missense variants (see PM1 specifications).",
            "applicability": "Not applicable",
            "baseStrength": "Pathogenic",
            "defaultStrength": "Pathogenic Supporting",
            "disease": [
              "MONDO:0004994",
              "MONDO:0005021",
              "MONDO:0005045",
              "MONDO:0005201",
              "MONDO:0009144"
            ],
            "evidenceCategory": "Functional Data",
            "gene": [
              "MYH7"
            ],
            "geneType": "nuclear",
            "label": "PP2",
            "ns": "002",
            "originalACMGSummary": "Missense variant in a gene that has a low rate of benign missense variation and where missense variants are a common mechanism of disease.",
            "sepioID": "SEPIO-CG:99034",
            "specificationType": [],
            "status": {
              "Pilot Rules In Prep": {
                "completed": true
              }
            },
            "strengthDescriptor": [
              {
                "applicability": "Not applicable",
                "id": "0237",
                "instructionsToUse": "",
                "status": "not approved",
                "strength": "Stand Alone",
                "strengthSepioID": "",
                "text": "",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Not applicable",
                "id": "0049",
                "instructionsToUse": "",
                "status": "not approved",
                "strength": "Very Strong",
                "strengthSepioID": "SEPIO:0000220",
                "text": "",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Not applicable",
                "id": "0033",
                "instructionsToUse": "",
                "status": "not approved",
                "strength": "Strong",
                "strengthSepioID": "SEPIO:0000330",
                "text": "",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Not applicable",
                "id": "0034",
                "instructionsToUse": "",
                "status": "not approved",
                "strength": "Moderate",
                "strengthSepioID": "SEPIO:0000216",
                "text": "",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Not applicable",
                "id": "0061",
                "instructionsToUse": "",
                "status": "not approved",
                "strength": "Supporting",
                "strengthSepioID": "SEPIO:0000329",
                "text": "",
                "type": "EvidenceLineStrength"
              }
            ]
          },
          "entType": "CriteriaCode",
          "ldhId": "135637792",
          "ldhIri": "https://cspec.genome.network/cspec/CriteriaCode/id/135637792",
          "modified": "2024-04-22T15:42:56.196Z",
          "modifier": "makelly2",
          "rev": "_inf5Aq---I"
        },
        {
          "entContent": {
            "_uniqueProp": "002_BP1_nuclear_MYH7",
            "additionalComments": "For the current genes where null variants are a known mechanism, pathogenic missense variants have also been reported.",
            "applicability": "Not applicable",
            "baseStrength": "Benign",
            "defaultStrength": "Benign Supporting",
            "disease": [
              "MONDO:0004994",
              "MONDO:0005021",
              "MONDO:0005045",
              "MONDO:0005201",
              "MONDO:0009144"
            ],
            "evidenceCategory": "Computational And Predictive Data",
            "gene": [
              "MYH7"
            ],
            "geneType": "nuclear",
            "label": "BP1",
            "ns": "002",
            "originalACMGSummary": "Missense variant in a gene for which primarily truncating variants are known to cause disease.",
            "sepioID": "SEPIO-CG:99043",
            "specificationType": [],
            "status": {
              "Pilot Rules In Prep": {
                "completed": true
              }
            },
            "strengthDescriptor": [
              {
                "applicability": "Not applicable",
                "id": "0206",
                "instructionsToUse": "",
                "status": "not approved",
                "strength": "Stand Alone",
                "strengthSepioID": "SEPIO:0000325",
                "text": "",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Not applicable",
                "id": "0204",
                "instructionsToUse": "",
                "status": "not approved",
                "strength": "Very Strong",
                "strengthSepioID": "",
                "text": "",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Not applicable",
                "id": "0075",
                "instructionsToUse": "",
                "status": "not approved",
                "strength": "Strong",
                "strengthSepioID": "SEPIO:0000328",
                "text": "",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Not applicable",
                "id": "0205",
                "instructionsToUse": "",
                "status": "not approved",
                "strength": "Moderate",
                "strengthSepioID": "SEPIO:0000699",
                "text": "",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Not applicable",
                "id": "0082",
                "instructionsToUse": "",
                "status": "not approved",
                "strength": "Supporting",
                "strengthSepioID": "SEPIO:0000327",
                "text": "",
                "type": "EvidenceLineStrength"
              }
            ]
          },
          "entType": "CriteriaCode",
          "ldhId": "135637778",
          "ldhIri": "https://cspec.genome.network/cspec/CriteriaCode/id/135637778",
          "modified": "2024-04-22T15:42:56.196Z",
          "modifier": "makelly2",
          "rev": "_inf5AqS--H"
        },
        {
          "entContent": {
            "_uniqueProp": "002_PM5_nuclear_MYH7",
            "additionalComments": "",
            "applicability": "Applicable",
            "baseStrength": "Pathogenic",
            "defaultStrength": "Pathogenic Moderate",
            "disease": [
              "MONDO:0004994",
              "MONDO:0005021",
              "MONDO:0005045",
              "MONDO:0005201",
              "MONDO:0009144"
            ],
            "evidenceCategory": "Computational And Predictive Data",
            "gene": [
              "MYH7"
            ],
            "geneType": "nuclear",
            "label": "PM5",
            "ns": "002",
            "originalACMGSummary": "Novel missense change at an amino acid residue where a different missense change determined to be pathogenic has been seen before.\nExample: Arg156His is pathogenic; now you observe Arg156Cys.\nCaveat: Beware of changes that impact splicing rather than at the amino acid/protein level.",
            "sepioID": "SEPIO-CG:99031",
            "specificationType": [],
            "status": {
              "Pilot Rules In Prep": {
                "completed": true
              }
            },
            "strengthDescriptor": [
              {
                "applicability": "Not applicable",
                "id": "0234",
                "instructionsToUse": "",
                "status": "not approved",
                "strength": "Stand Alone",
                "strengthSepioID": "",
                "text": "",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Not applicable",
                "id": "0047",
                "instructionsToUse": "",
                "status": "not approved",
                "strength": "Very Strong",
                "strengthSepioID": "SEPIO:0000220",
                "text": "",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Not Applicable",
                "id": "0056",
                "instructionsToUse": "",
                "status": "not approved",
                "strength": "Strong",
                "strengthSepioID": "SEPIO:0000330",
                "text": "",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Applicable",
                "id": "105",
                "instructionsToUse": "",
                "specificationType": [
                  "General recommendation"
                ],
                "status": "approved",
                "strength": "Moderate",
                "strengthSepioID": "SEPIO:0000216",
                "text": "This criterion can be used at MODERATE if a different missense variant at the same codon has been classified as _pathogenic_ using these modified guidelines without application of PM5.\n\nThe impact of the amino acid change being evaluated needs to be compared to the impact of the amino acid change that is established as pathogenic (e.g., a change of Ala to His is less severe than Ala to Cys change). Consider reducing the strength of this rule to SUPPORTING if the predicted impact is not expected to be equivalent or more severe.\n\nPM5 should not be combined with PM1.  If both are applicable at MODERATE weight, use of PM5 is most appropriate since it is variant specific.",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Applicable",
                "id": "0048",
                "instructionsToUse": "",
                "specificationType": [
                  "General recommendation"
                ],
                "status": "not approved",
                "strength": "Supporting",
                "strengthSepioID": "SEPIO:0000329",
                "text": "This criterion can be considered at SUPPORTING if a different missense variant at the same codon has been classified as _likely pathogenic_ using these modified guidelines without application of PM5.\n\nThe impact of the amino acid change being evaluated needs to be compared to the impact of the amino acid change that is established as likely pathogenic (e.g., a change of Ala to His is less severe than Ala to Cys change). Consider reducing the strength of this rule to NOT APPLICABLE if the predicted impact is not expected to be equivalent or more severe.\n\nPM5 should not be combined with PM1.  The one with the higher strength should be applied, but if both are applicable at SUPPORTING weight, use of PM5 is most appropriate since it is variant specific.",
                "type": "EvidenceLineStrength"
              }
            ]
          },
          "entType": "CriteriaCode",
          "ldhId": "135637777",
          "ldhIri": "https://cspec.genome.network/cspec/CriteriaCode/id/135637777",
          "modified": "2024-04-22T15:42:56.196Z",
          "modifier": "makelly2",
          "rev": "_inf5AqS--E"
        },
        {
          "entContent": {
            "_uniqueProp": "002_BS2_nuclear_MYH7",
            "additionalComments": "Inherited cardiomyopathies generally display reduced penetrance, variable expressivity, and adult-onset. ",
            "applicability": "Not applicable",
            "baseStrength": "Benign",
            "defaultStrength": "Benign Strong",
            "disease": [
              "MONDO:0004994",
              "MONDO:0005021",
              "MONDO:0005045",
              "MONDO:0005201",
              "MONDO:0009144"
            ],
            "evidenceCategory": "Population Data",
            "gene": [
              "MYH7"
            ],
            "geneType": "nuclear",
            "label": "BS2",
            "ns": "002",
            "originalACMGSummary": "Observed in a healthy adult individual for a recessive (homozygous), dominant (heterozygous), or X-linked (hemizygous) disorder, with full penetrance expected at an early age.",
            "sepioID": "SEPIO-CG:99040",
            "specificationType": [],
            "status": {
              "Pilot Rules In Prep": {
                "completed": true
              }
            },
            "strengthDescriptor": [
              {
                "applicability": "Not applicable",
                "id": "0091",
                "instructionsToUse": "",
                "status": "not approved",
                "strength": "Stand Alone",
                "strengthSepioID": "SEPIO:0000357",
                "text": "",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Not applicable",
                "id": "0224",
                "instructionsToUse": "",
                "status": "not approved",
                "strength": "Very Strong",
                "strengthSepioID": "",
                "text": "",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Not applicable",
                "id": "0069",
                "instructionsToUse": "",
                "status": "not approved",
                "strength": "Strong",
                "strengthSepioID": "SEPIO:0000328",
                "text": "",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Not applicable",
                "id": "0098",
                "instructionsToUse": "",
                "status": "not approved",
                "strength": "Moderate",
                "strengthSepioID": "SEPIO:0000699",
                "text": "",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Not applicable",
                "id": "0076",
                "instructionsToUse": "",
                "status": "not approved",
                "strength": "Supporting",
                "strengthSepioID": "SEPIO:0000327",
                "text": "",
                "type": "EvidenceLineStrength"
              }
            ]
          },
          "entType": "CriteriaCode",
          "ldhId": "135637774",
          "ldhIri": "https://cspec.genome.network/cspec/CriteriaCode/id/135637774",
          "modified": "2024-04-22T15:42:56.196Z",
          "modifier": "makelly2",
          "rev": "_inf5AqG--n"
        },
        {
          "entContent": {
            "_uniqueProp": "002_PM3_nuclear_MYH7",
            "additionalComments": "It is acknowledged that there is increasing evidence supporting that some of these genes/variants may also be recessive (e.g., MYL2, MYL3), but addressing those edge cases was outside the scope of this current guideline.",
            "applicability": "Not applicable",
            "baseStrength": "Pathogenic",
            "defaultStrength": "Pathogenic Moderate",
            "disease": [
              "MONDO:0004994",
              "MONDO:0005021",
              "MONDO:0005045",
              "MONDO:0005201",
              "MONDO:0009144"
            ],
            "evidenceCategory": "Allelic Data",
            "gene": [
              "MYH7"
            ],
            "geneType": "nuclear",
            "label": "PM3",
            "ns": "002",
            "originalACMGSummary": "For recessive disorders, detected in trans with a pathogenic variant\nNote: This requires testing of parents (or offspring) to determine phase.",
            "sepioID": "SEPIO-CG:99029",
            "specificationType": [],
            "status": {
              "Pilot Rules In Prep": {
                "completed": true
              }
            },
            "strengthDescriptor": [
              {
                "applicability": "Not applicable",
                "id": "0232",
                "instructionsToUse": "",
                "status": "not approved",
                "strength": "Stand Alone",
                "strengthSepioID": "",
                "text": "",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Not applicable",
                "id": "0038",
                "instructionsToUse": "",
                "status": "not approved",
                "strength": "Very Strong",
                "strengthSepioID": "SEPIO:0000220",
                "text": "",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Not applicable",
                "id": "0058",
                "instructionsToUse": "",
                "status": "not approved",
                "strength": "Strong",
                "strengthSepioID": "SEPIO:0000330",
                "text": "",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Not applicable",
                "id": "007",
                "instructionsToUse": "",
                "status": "not approved",
                "strength": "Moderate",
                "strengthSepioID": "SEPIO:0000216",
                "text": "",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Not applicable",
                "id": "0027",
                "instructionsToUse": "",
                "status": "not approved",
                "strength": "Supporting",
                "strengthSepioID": "SEPIO:0000329",
                "text": "",
                "type": "EvidenceLineStrength"
              }
            ]
          },
          "entType": "CriteriaCode",
          "ldhId": "135637773",
          "ldhIri": "https://cspec.genome.network/cspec/CriteriaCode/id/135637773",
          "modified": "2024-04-22T15:42:56.196Z",
          "modifier": "makelly2",
          "rev": "_inf5AqW--X"
        },
        {
          "entContent": {
            "_uniqueProp": "002_PM2_nuclear_MYH7",
            "additionalComments": "",
            "applicability": "Applicable",
            "baseStrength": "Pathogenic",
            "defaultStrength": "Pathogenic Moderate",
            "disease": [
              "MONDO:0004994",
              "MONDO:0005021",
              "MONDO:0005045",
              "MONDO:0005201",
              "MONDO:0009144"
            ],
            "evidenceCategory": "Population Data",
            "gene": [
              "MYH7"
            ],
            "geneType": "nuclear",
            "label": "PM2",
            "ns": "002",
            "originalACMGSummary": "Absent from controls (or at extremely low frequency if recessive) in Exome Sequencing Project, 1000 Genomes or Exome Aggregation Consortium.\nCaveat: Population data for indels may be poorly called by next generation sequencing.",
            "sepioID": "SEPIO-CG:99028",
            "specificationType": [],
            "status": {
              "Pilot Rules In Prep": {
                "completed": true
              }
            },
            "strengthDescriptor": [
              {
                "applicability": "Not applicable",
                "id": "0231",
                "instructionsToUse": "",
                "status": "not approved",
                "strength": "Stand Alone",
                "strengthSepioID": "",
                "text": "",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Not applicable",
                "id": "0044",
                "instructionsToUse": "",
                "status": "not approved",
                "strength": "Very Strong",
                "strengthSepioID": "SEPIO:0000220",
                "text": "",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Not applicable",
                "id": "0013",
                "instructionsToUse": "",
                "status": "not approved",
                "strength": "Strong",
                "strengthSepioID": "SEPIO:0000330",
                "text": "",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Not Applicable",
                "id": "104",
                "instructionsToUse": "",
                "specificationType": [
                  "Disease-specific",
                  "Gene-specific"
                ],
                "status": "approved",
                "strength": "Moderate",
                "strengthSepioID": "SEPIO:0000216",
                "text": "",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Applicable",
                "id": "0030",
                "instructionsToUse": "",
                "specificationType": [
                  "Disease-specific"
                ],
                "status": "not approved",
                "strength": "Supporting",
                "strengthSepioID": "SEPIO:0000329",
                "text": "The values used to calculate the PM2 thresholds were derived from studies in Northern European populations that have been relatively well-characterized with regards to disease prevalence and variant spectrum. These thresholds can be applied to any population where disease prevalence is considered comparable (1/500 or lower), where the most frequent pathogenic variant accounts for no more than 2% of cases (e.g., has an allele frequency of ≤0.02 in cases based on the upper bound of 95% CI), and where the penetrance of a pathogenic variant is expected to be at least 50% (Kelly _et al._ 2018[<sup>11</sup>](#pmid_29300372)).\n\nA threshold of **≤0.00004** in the subpopulation with the highest frequency when using the upper bound of the 95% CI activates this rule.\n\n1.  Alternatively, this is equivalent to the variant NOT being observed more than once (≤1 allele) in gnomAD v.2.1.1 in one of the non-founder populations (e.g., absence required from the Other and Ashkenazi Jewish subpopulations).\n2.  Applying a threshold of ≤0.00004 (upper bound of 95% CI of the allele frequency in gnomAD) is equivalent to the variant being seen in a single subpopulation and that subpopulation meets any of the following:\n    *   **Allele Count (AC) in Allele Number (AN)**\n    *   ≤1 in ≥120,000\n    *   ≤2 in ≥160,000\n    *   ≤3 in ≥195,000\n    *   ≤4 in ≥230,000\n\ngnomAD is the preferred database for this calculation, but currently only displays the filtering allele frequency (FAF), which is equivalent to a lower bound estimate of the 95% CI, when the upper bound is what is needed.\n\n*   Confidence interval tools, such as [Confit-de-MAF](https://www.genecalculators.net/confit-de-maf.html), can be used to determine the upper bound of the 95% CI of the observed allele frequency.\n\nDue to current technical limitations of next generation sequencing technologies, minor allele frequencies for complex variants (e.g., large indels) may not be accurately represented in population databases.\n\nCaution should be used when a variant is only identified, or over-represented, in one of the smaller gnomAD populations, as the gnomAD allele frequencies may not accurately represent the true population frequency.\n\nPopulation databases may contain affected or pre-symptomatic individuals for diseases with reduced penetrance/variable onset.",
                "type": "EvidenceLineStrength"
              }
            ]
          },
          "entType": "CriteriaCode",
          "ldhId": "135637797",
          "ldhIri": "https://cspec.genome.network/cspec/CriteriaCode/id/135637797",
          "modified": "2024-04-22T15:42:56.196Z",
          "modifier": "makelly2",
          "rev": "_inf5Ap2--d"
        },
        {
          "entContent": {
            "_uniqueProp": "002_PM1_nuclear_MYH7",
            "additionalComments": "",
            "applicability": "Applicable",
            "baseStrength": "Pathogenic",
            "defaultStrength": "Pathogenic Moderate",
            "disease": [
              "MONDO:0004994",
              "MONDO:0005021",
              "MONDO:0005045",
              "MONDO:0005201",
              "MONDO:0009144"
            ],
            "evidenceCategory": "Functional Data",
            "gene": [
              "MYH7"
            ],
            "geneType": "nuclear",
            "label": "PM1",
            "ns": "002",
            "originalACMGSummary": "Located in a mutational hot spot and/or critical and well-established functional domain (e.g. active site of an enzyme) without benign variation.",
            "sepioID": "SEPIO-CG:99027",
            "specificationType": [],
            "status": {
              "Pilot Rules In Prep": {
                "completed": true
              }
            },
            "strengthDescriptor": [
              {
                "applicability": "Not applicable",
                "id": "0230",
                "instructionsToUse": "",
                "status": "not approved",
                "strength": "Stand Alone",
                "strengthSepioID": "",
                "text": "",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Not applicable",
                "id": "0015",
                "instructionsToUse": "",
                "status": "not approved",
                "strength": "Very Strong",
                "strengthSepioID": "SEPIO:0000220",
                "text": "",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Not Applicable",
                "id": "0028",
                "instructionsToUse": "",
                "status": "not approved",
                "strength": "Strong",
                "strengthSepioID": "SEPIO:0000330",
                "text": "",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Applicable",
                "id": "107",
                "instructionsToUse": "",
                "specificationType": [
                  "Disease-specific",
                  "Gene-specific"
                ],
                "status": "approved",
                "strength": "Moderate",
                "strengthSepioID": "SEPIO:0000216",
                "text": "Applicable to missense variants in _MYH7_ in the specific regions listed below (Walsh _et al._ 2019[<sup>10</sup>](#pmid_30696458)). \n\n1.  Transcripts ENST00000355349 & NM\\_000257.4\n2.  Codons 167-931\\*\n\nData from HCM case cohorts was used to derive these cluster regions. Therefore, this rule should NOT be applied when additional evidence for the variant supports that the variant causes a phenotype other than HCM (e.g., variant seen in multiple DCM cases).\n\nEnrichment was not observed for DCM in any genes.\n\nRule should NOT be combined with PM5 because presence of pathogenic variants in the same codon/region were used to determine clustering and would be double-counting evidence.\n\n_\\* This region is updated from v1.0 (Kelly et al. 2018_[_<sup>11</sup>_](#pmid_29300372)_)._",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Not Applicable",
                "id": "0054",
                "instructionsToUse": "",
                "status": "not approved",
                "strength": "Supporting",
                "strengthSepioID": "SEPIO:0000329",
                "text": "",
                "type": "EvidenceLineStrength"
              }
            ]
          },
          "entType": "CriteriaCode",
          "ldhId": "135637796",
          "ldhIri": "https://cspec.genome.network/cspec/CriteriaCode/id/135637796",
          "modified": "2024-04-22T15:42:56.196Z",
          "modifier": "makelly2",
          "rev": "_inf5AqS--K"
        },
        {
          "entContent": {
            "_uniqueProp": "002_PP4_nuclear_MYH7",
            "additionalComments": "Inherited cardiomyopathies have high locus heterogeneity as well as non-genetic etiologies. ",
            "applicability": "Not applicable",
            "baseStrength": "Pathogenic",
            "defaultStrength": "Pathogenic Supporting",
            "disease": [
              "MONDO:0004994",
              "MONDO:0005021",
              "MONDO:0005045",
              "MONDO:0005201",
              "MONDO:0009144"
            ],
            "evidenceCategory": "Other Data",
            "gene": [
              "MYH7"
            ],
            "geneType": "nuclear",
            "label": "PP4",
            "ns": "002",
            "originalACMGSummary": "Patient’s phenotype or family history is highly specific for a disease with a single genetic etiology.",
            "sepioID": "SEPIO-CG:99036",
            "specificationType": [],
            "status": {
              "Pilot Rules In Prep": {
                "completed": true
              }
            },
            "strengthDescriptor": [
              {
                "applicability": "Not applicable",
                "id": "0239",
                "instructionsToUse": "",
                "status": "not approved",
                "strength": "Stand Alone",
                "strengthSepioID": "",
                "text": "",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Not applicable",
                "id": "002",
                "instructionsToUse": "",
                "status": "not approved",
                "strength": "Very Strong",
                "strengthSepioID": "SEPIO:0000220",
                "text": "",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Not applicable",
                "id": "005",
                "instructionsToUse": "",
                "status": "not approved",
                "strength": "Strong",
                "strengthSepioID": "SEPIO:0000330",
                "text": "",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Not applicable",
                "id": "0018",
                "instructionsToUse": "",
                "status": "not approved",
                "strength": "Moderate",
                "strengthSepioID": "SEPIO:0000216",
                "text": "",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Not applicable",
                "id": "0063",
                "instructionsToUse": "",
                "status": "not approved",
                "strength": "Supporting",
                "strengthSepioID": "SEPIO:0000329",
                "text": "",
                "type": "EvidenceLineStrength"
              }
            ]
          },
          "entType": "CriteriaCode",
          "ldhId": "135637795",
          "ldhIri": "https://cspec.genome.network/cspec/CriteriaCode/id/135637795",
          "modified": "2024-04-22T15:42:56.196Z",
          "modifier": "makelly2",
          "rev": "_inf5AqW--Z"
        },
        {
          "entContent": {
            "_uniqueProp": "002_BP5_nuclear_MYH7",
            "additionalComments": "Co-occurrence with an established pathogenic or likely pathogenic variant for a non-cardiomyopathy related disease does not reduce the likelihood that a variant is independently disease-causing for cardiomyopathy.",
            "applicability": "Not applicable",
            "baseStrength": "Benign",
            "defaultStrength": "Benign Supporting",
            "disease": [
              "MONDO:0004994",
              "MONDO:0005021",
              "MONDO:0005045",
              "MONDO:0005201",
              "MONDO:0009144"
            ],
            "evidenceCategory": "Other Data",
            "gene": [
              "MYH7"
            ],
            "geneType": "nuclear",
            "label": "BP5",
            "ns": "002",
            "originalACMGSummary": "Variant found in a case with an alternate molecular basis for disease.",
            "sepioID": "SEPIO-CG:99047",
            "specificationType": [],
            "status": {
              "Pilot Rules In Prep": {
                "completed": true
              }
            },
            "strengthDescriptor": [
              {
                "applicability": "Not applicable",
                "id": "0218",
                "instructionsToUse": "",
                "status": "not approved",
                "strength": "Stand Alone",
                "strengthSepioID": "SEPIO:0000325",
                "text": "",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Not applicable",
                "id": "0216",
                "instructionsToUse": "",
                "status": "not approved",
                "strength": "Very Strong",
                "strengthSepioID": "",
                "text": "",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Not applicable",
                "id": "0073",
                "instructionsToUse": "",
                "status": "not approved",
                "strength": "Strong",
                "strengthSepioID": "SEPIO:0000328",
                "text": "",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Not applicable",
                "id": "0217",
                "instructionsToUse": "",
                "status": "not approved",
                "strength": "Moderate",
                "strengthSepioID": "SEPIO:0000699",
                "text": "",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Not applicable",
                "id": "119",
                "instructionsToUse": "",
                "specificationType": [
                  "Disease-specific",
                  "Gene-specific"
                ],
                "status": "approved",
                "strength": "Supporting",
                "strengthSepioID": "SEPIO:0000327",
                "text": "",
                "type": "EvidenceLineStrength"
              }
            ]
          },
          "entType": "CriteriaCode",
          "ldhId": "135637790",
          "ldhIri": "https://cspec.genome.network/cspec/CriteriaCode/id/135637790",
          "modified": "2024-04-22T15:42:56.196Z",
          "modifier": "makelly2",
          "rev": "_inf5AqG--l"
        },
        {
          "entContent": {
            "_uniqueProp": "002_PM6_nuclear_MYH7",
            "additionalComments": "",
            "applicability": "Applicable",
            "baseStrength": "Pathogenic",
            "defaultStrength": "Pathogenic Moderate",
            "disease": [
              "MONDO:0004994",
              "MONDO:0005021",
              "MONDO:0005045",
              "MONDO:0005201",
              "MONDO:0009144"
            ],
            "evidenceCategory": "De novo Data",
            "gene": [
              "MYH7"
            ],
            "geneType": "nuclear",
            "label": "PM6",
            "ns": "002",
            "originalACMGSummary": "Assumed de novo, but without confirmation of paternity and maternity.",
            "sepioID": "SEPIO-CG:99032",
            "specificationType": [],
            "status": {
              "Pilot Rules In Prep": {
                "completed": true
              }
            },
            "strengthDescriptor": [
              {
                "applicability": "Not applicable",
                "id": "0235",
                "instructionsToUse": "",
                "status": "not approved",
                "strength": "Stand Alone",
                "strengthSepioID": "",
                "text": "",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Not applicable",
                "id": "0014",
                "instructionsToUse": "",
                "status": "not approved",
                "strength": "Very Strong",
                "strengthSepioID": "SEPIO:0000220",
                "text": "",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Not Applicable",
                "id": "0037",
                "instructionsToUse": "",
                "status": "not approved",
                "strength": "Strong",
                "strengthSepioID": "SEPIO:0000330",
                "text": "",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Applicable",
                "id": "106",
                "instructionsToUse": "",
                "specificationType": [
                  "Disease-specific"
                ],
                "status": "approved",
                "strength": "Moderate",
                "strengthSepioID": "SEPIO:0000216",
                "text": "Refer to SVI guidance on number/combination of cases required based on phenotype specificity[<sup>2</sup>](#url_c73e109e-b916-5a72-b7b1-1762446f3c11).\n\nFor most cardiomyopathies, it is recommended to default to “phenotype consistent with gene but not highly specific”. Clinical judgment is required for shifting to a higher or lower phenotypic consistency. \n\nSee PS2 for additional considerations.",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Not Applicable",
                "id": "0022",
                "instructionsToUse": "",
                "status": "not approved",
                "strength": "Supporting",
                "strengthSepioID": "SEPIO:0000329",
                "text": "",
                "type": "EvidenceLineStrength"
              }
            ]
          },
          "entType": "CriteriaCode",
          "ldhId": "135637780",
          "ldhIri": "https://cspec.genome.network/cspec/CriteriaCode/id/135637780",
          "modified": "2024-04-22T15:42:56.196Z",
          "modifier": "makelly2",
          "rev": "_inf5AqS--D"
        },
        {
          "entContent": {
            "_uniqueProp": "002_PVS1_nuclear_MYH7",
            "additionalComments": "Not applicable for MYH7.",
            "applicability": "Not applicable",
            "baseStrength": "Pathogenic",
            "defaultStrength": "Pathogenic Very Strong",
            "disease": [
              "MONDO:0004994",
              "MONDO:0005021",
              "MONDO:0005045",
              "MONDO:0005201",
              "MONDO:0009144"
            ],
            "evidenceCategory": "Computational And Predictive Data",
            "gene": [
              "MYH7"
            ],
            "geneType": "nuclear",
            "label": "PVS1",
            "ns": "002",
            "originalACMGSummary": "Null variant (nonsense, frameshift, canonical +/−1 or 2 splice sites, initiation codon, single or multi-exon deletion) in a gene where loss of function (LOF) is a known mechanism of disease.\nCaveats:\n * Beware of genes where LOF is not a known disease mechanism (e.g. GFAP, MYH7).\n * Use caution interpreting LOF variants at the extreme 3’ end of a gene.\n * Use caution with splice variants that are predicted to lead to exon skipping but leave the remainder of the protein intact.\n * Use caution in the presence of multiple transcripts.",
            "sepioID": "SEPIO-CG:99022",
            "specificationType": [],
            "status": {
              "Pilot Rules In Prep": {
                "completed": true
              }
            },
            "strengthDescriptor": [
              {
                "applicability": "Not applicable",
                "id": "0245",
                "instructionsToUse": "",
                "status": "not approved",
                "strength": "Stand Alone",
                "strengthSepioID": "",
                "text": "",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Not applicable",
                "id": "0244",
                "instructionsToUse": "",
                "status": "not approved",
                "strength": "Very Strong",
                "strengthSepioID": "SEPIO:0000220",
                "text": "",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Not applicable",
                "id": "0020",
                "instructionsToUse": "",
                "status": "not approved",
                "strength": "Strong",
                "strengthSepioID": "SEPIO:0000330",
                "text": "",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Not applicable",
                "id": "114",
                "instructionsToUse": "",
                "specificationType": [
                  "Modified rule strength"
                ],
                "status": "approved",
                "strength": "Moderate",
                "strengthSepioID": "SEPIO:0000216",
                "text": "",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Not applicable",
                "id": "001",
                "instructionsToUse": "",
                "status": "not approved",
                "strength": "Supporting",
                "strengthSepioID": "SEPIO:0000329",
                "text": "",
                "type": "EvidenceLineStrength"
              }
            ]
          },
          "entType": "CriteriaCode",
          "ldhId": "135637789",
          "ldhIri": "https://cspec.genome.network/cspec/CriteriaCode/id/135637789",
          "modified": "2024-04-22T15:42:56.196Z",
          "modifier": "makelly2",
          "rev": "_inf5AqG--k"
        },
        {
          "entContent": {
            "_uniqueProp": "002_PP1_nuclear_MYH7",
            "additionalComments": "",
            "applicability": "Applicable",
            "baseStrength": "Pathogenic",
            "defaultStrength": "Pathogenic Supporting",
            "disease": [
              "MONDO:0004994",
              "MONDO:0005021",
              "MONDO:0005045",
              "MONDO:0005201",
              "MONDO:0009144"
            ],
            "evidenceCategory": "Segregation Data",
            "gene": [
              "MYH7"
            ],
            "geneType": "nuclear",
            "label": "PP1",
            "ns": "002",
            "originalACMGSummary": "Co-segregation with disease in multiple affected family members in a gene definitively known to cause the disease.\nNote: May be used as stronger evidence with increasing segregation data.",
            "sepioID": "SEPIO-CG:99033",
            "specificationType": [],
            "status": {
              "Pilot Rules In Prep": {
                "completed": true
              }
            },
            "strengthDescriptor": [
              {
                "applicability": "Not applicable",
                "id": "0236",
                "instructionsToUse": "",
                "status": "not approved",
                "strength": "Stand Alone",
                "strengthSepioID": "",
                "text": "",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Not applicable",
                "id": "0042",
                "instructionsToUse": "",
                "status": "not approved",
                "strength": "Very Strong",
                "strengthSepioID": "SEPIO:0000220",
                "text": "",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Applicable",
                "id": "103",
                "instructionsToUse": "",
                "specificationType": [
                  "Disease-specific"
                ],
                "status": "approved",
                "strength": "Strong",
                "strengthSepioID": "SEPIO:0000330",
                "text": "Due to the genotypic and phenotypic heterogeneity of inherited cardiomyopathies, segregation thresholds have been conservatively set at **≥7 segregations** (LOD score of 2.1) for **STRONG**.\n\nAlthough rare for inherited cardiomyopathies, when the phenotype/presentation of a variant within and across families is highly specific (e.g., early-onset severe RCM in all affected individuals), the following thresholds as proposed by Jarvik and Browning (2016)[<sup>12</sup>](#pmid_27236918) can be considered: \n\n*   STRONG evidence requires ≥5 segregations (LOD score of 1.5)\n\nOnly genotype positive/phenotype positive individuals are counted as segregations, which can include affected obligate carriers. Genotype positive/phenotype negative individuals are generally less informative for cardiomyopathy genes due to variable age at onset and reduced penetrance.\n\nPhenotypes should be clinically confirmed, whenever possible, and should not include individuals with a suspected diagnosis.  \n\nImportant considerations include:\n\n1.  Segregation of a variant within a single family or haplotype has the potential to represent linkage disequilibrium with another undetected variant.  If linkage disequilibrium is a concern, consider downgrading strength of segregation. \n2.  Use of segregation criteria should be carefully evaluated if variant frequency meets criteria for BS1.\n3.  Caution is needed when counting segregations in presence of other possible disease-causing variants, as both variants may be contributing to the phenotype. \n4.  Caution is needed when distantly related (≥3<sup>rd</sup> degree) affected individuals are connected by unknown or unaffected relatives (raises possibility of multiple causes of disease).",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Applicable",
                "id": "113",
                "instructionsToUse": "",
                "specificationType": [
                  "Disease-specific"
                ],
                "status": "approved",
                "strength": "Moderate",
                "strengthSepioID": "SEPIO:0000216",
                "text": "Due to the genotypic and phenotypic heterogeneity of inherited cardiomyopathies, segregation thresholds have been conservatively set at **≥5** **segregations** (LOD score of 1.5) for **MODERATE**.\n\nAlthough rare for inherited cardiomyopathies, when the phenotype/presentation of a variant within and across families is highly specific (e.g., early-onset severe RCM in all affected individuals), the following thresholds as proposed by Jarvik and Browning (2016)[<sup>12</sup>](#pmid_27236918) can be considered: \n\n*   MODERATE evidence requires ≥4 segregations (LOD score of 1.2)\n\nOnly genotype positive/phenotype positive individuals are counted as segregations, which can include affected obligate carriers. Genotype positive/phenotype negative individuals are generally less informative for cardiomyopathy genes due to variable age at onset and reduced penetrance.\n\nPhenotypes should be clinically confirmed, whenever possible, and should not include individuals with a suspected diagnosis.  \n\nImportant considerations include:\n\n1.  Segregation of a variant within a single family or haplotype has the potential to represent linkage disequilibrium with another undetected variant.  If linkage disequilibrium is a concern, consider downgrading strength of segregation. \n2.  Use of segregation criteria should be carefully evaluated if variant frequency meets criteria for BS1 (see below).\n3.  Caution is needed when counting segregations in presence of other possible disease-causing variants, as both variants may be contributing to the phenotype. \n4.  Caution is needed when distantly related (≥3<sup>rd</sup> degree) affected individuals are connected by unknown or unaffected relatives (raises possibility of multiple causes of disease).",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Applicable",
                "id": "101",
                "instructionsToUse": "",
                "specificationType": [
                  "Disease-specific"
                ],
                "status": "approved",
                "strength": "Supporting",
                "strengthSepioID": "SEPIO:0000329",
                "text": "Due to the genotypic and phenotypic heterogeneity of inherited cardiomyopathies, segregation thresholds have been conservatively set at **≥3** **segregations** (LOD score of 0.9) for **SUPPORTING**. The thresholds as proposed by Jarvik and Browning (2016)[<sup>12</sup>](#pmid_27236918) are the same at ≥3 segregations (LOD score of 0.9) for supporting.\n\nOnly genotype positive/phenotype positive individuals are counted as segregations, which can include affected obligate carriers. Genotype positive/phenotype negative individuals are generally less informative for cardiomyopathy genes due to variable age at onset and reduced penetrance.\n\nPhenotypes should be clinically confirmed, whenever possible, and should not include individuals with a suspected diagnosis.  \n\nImportant considerations include:\n\n1.  Segregation of a variant within a single family or haplotype has the potential to represent linkage disequilibrium with another undetected variant.  If linkage disequilibrium is a concern, consider downgrading strength of segregation. \n2.  Use of segregation criteria should be carefully evaluated if variant frequency meets criteria for BS1 (see below).\n3.  Caution is needed when counting segregations in presence of other possible disease-causing variants, as both variants may be contributing to the phenotype. \n4.  Caution is needed when distantly related (≥3<sup>rd</sup> degree) affected individuals are connected by unknown or unaffected relatives (raises possibility of multiple causes of disease).",
                "type": "EvidenceLineStrength"
              }
            ]
          },
          "entType": "CriteriaCode",
          "ldhId": "135637787",
          "ldhIri": "https://cspec.genome.network/cspec/CriteriaCode/id/135637787",
          "modified": "2024-04-22T15:42:56.196Z",
          "modifier": "makelly2",
          "rev": "_inf5AqG--i"
        },
        {
          "entContent": {
            "_uniqueProp": "002_BP4_nuclear_MYH7",
            "additionalComments": "",
            "applicability": "Applicable",
            "baseStrength": "Benign",
            "defaultStrength": "Benign Supporting",
            "disease": [
              "MONDO:0004994",
              "MONDO:0005021",
              "MONDO:0005045",
              "MONDO:0005201",
              "MONDO:0009144"
            ],
            "evidenceCategory": "Computational And Predictive Data",
            "gene": [
              "MYH7"
            ],
            "geneType": "nuclear",
            "label": "BP4",
            "ns": "002",
            "originalACMGSummary": "Multiple lines of computational evidence suggest no impact on gene or gene product (conservation, evolutionary, splicing impact, etc)\nCaveat: As many in silico algorithms use the same or very similar input for their predictions, each algorithm cannot be counted as an independent criterion. BP4 can be used only once in any evaluation of a variant.",
            "sepioID": "SEPIO-CG:99046",
            "specificationType": [],
            "status": {
              "Pilot Rules In Prep": {
                "completed": true
              }
            },
            "strengthDescriptor": [
              {
                "applicability": "Not applicable",
                "id": "0215",
                "instructionsToUse": "",
                "status": "not approved",
                "strength": "Stand Alone",
                "strengthSepioID": "SEPIO:0000325",
                "text": "",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Not applicable",
                "id": "0213",
                "instructionsToUse": "",
                "status": "not approved",
                "strength": "Very Strong",
                "strengthSepioID": "",
                "text": "",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Not Applicable",
                "id": "0066",
                "instructionsToUse": "",
                "status": "not approved",
                "strength": "Strong",
                "strengthSepioID": "SEPIO:0000328",
                "text": "",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Not Applicable",
                "id": "0214",
                "instructionsToUse": "",
                "status": "not approved",
                "strength": "Moderate",
                "strengthSepioID": "SEPIO:0000699",
                "text": "",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Applicable",
                "id": "116",
                "instructionsToUse": "",
                "specificationType": [
                  "No change"
                ],
                "status": "approved",
                "strength": "Supporting",
                "strengthSepioID": "SEPIO:0000327",
                "text": "As many _in silico_ algorithms use the same or very similar input for their predictions, each algorithm should not be counted as an independent criterion. Meta-predictors, such as REVEL, are preferred over multiple individual predictors.\n\nUse of REVEL (Ioannidis et al. 2016[<sup>14</sup>](#pmid_27666373)) is recommended at thresholds of **≤0.40 for BP4**.\n\nClinical judgment is needed if any individual algorithms or conservation data are contradictory to REVEL data.\n\nPositive predictive value for benign/no impact predictions is generally higher than for pathogenic/impact predictions.\n\n[SpliceAI](https://spliceailookup.broadinstitute.org)[<sup>13</sup>](#pmid_30661751) is recommended for evaluation of predicted splice impacts.",
                "type": "EvidenceLineStrength"
              }
            ]
          },
          "entType": "CriteriaCode",
          "ldhId": "135637786",
          "ldhIri": "https://cspec.genome.network/cspec/CriteriaCode/id/135637786",
          "modified": "2024-04-22T15:42:56.196Z",
          "modifier": "makelly2",
          "rev": "_inf5AqG--m"
        },
        {
          "entContent": {
            "_uniqueProp": "002_BP3_nuclear_MYH7",
            "additionalComments": "Not applicable to the current genes. ",
            "applicability": "Not applicable",
            "baseStrength": "Benign",
            "defaultStrength": "Benign Supporting",
            "disease": [
              "MONDO:0004994",
              "MONDO:0005021",
              "MONDO:0005045",
              "MONDO:0005201",
              "MONDO:0009144"
            ],
            "evidenceCategory": "Computational And Predictive Data",
            "gene": [
              "MYH7"
            ],
            "geneType": "nuclear",
            "label": "BP3",
            "ns": "002",
            "originalACMGSummary": "In frame-deletions/insertions in a repetitive region without a known function.",
            "sepioID": "SEPIO-CG:99045",
            "specificationType": [],
            "status": {
              "Pilot Rules In Prep": {
                "completed": true
              }
            },
            "strengthDescriptor": [
              {
                "applicability": "Not applicable",
                "id": "0212",
                "instructionsToUse": "",
                "status": "not approved",
                "strength": "Stand Alone",
                "strengthSepioID": "SEPIO:0000325",
                "text": "",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Not applicable",
                "id": "0210",
                "instructionsToUse": "",
                "status": "not approved",
                "strength": "Very Strong",
                "strengthSepioID": "",
                "text": "",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Not applicable",
                "id": "0074",
                "instructionsToUse": "",
                "status": "not approved",
                "strength": "Strong",
                "strengthSepioID": "SEPIO:0000328",
                "text": "",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Not applicable",
                "id": "0211",
                "instructionsToUse": "",
                "status": "not approved",
                "strength": "Moderate",
                "strengthSepioID": "SEPIO:0000699",
                "text": "",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Not applicable",
                "id": "0081",
                "instructionsToUse": "",
                "status": "not approved",
                "strength": "Supporting",
                "strengthSepioID": "SEPIO:0000327",
                "text": "",
                "type": "EvidenceLineStrength"
              }
            ]
          },
          "entType": "CriteriaCode",
          "ldhId": "135637784",
          "ldhIri": "https://cspec.genome.network/cspec/CriteriaCode/id/135637784",
          "modified": "2024-04-22T15:42:56.196Z",
          "modifier": "makelly2",
          "rev": "_inf5AqS--F"
        },
        {
          "entContent": {
            "_uniqueProp": "002_BP2_nuclear_MYH7",
            "additionalComments": "",
            "applicability": "Applicable",
            "baseStrength": "Benign",
            "defaultStrength": "Benign Supporting",
            "disease": [
              "MONDO:0004994",
              "MONDO:0005021",
              "MONDO:0005045",
              "MONDO:0005201",
              "MONDO:0009144"
            ],
            "evidenceCategory": "Allelic Data",
            "gene": [
              "MYH7"
            ],
            "geneType": "nuclear",
            "label": "BP2",
            "ns": "002",
            "originalACMGSummary": "Observed in trans with a pathogenic variant for a fully penetrant dominant gene/disorder or observed in cis with a pathogenic variant in any inheritance pattern.",
            "sepioID": "SEPIO-CG:99044",
            "specificationType": [],
            "status": {
              "Pilot Rules In Prep": {
                "completed": true
              }
            },
            "strengthDescriptor": [
              {
                "applicability": "Not applicable",
                "id": "0209",
                "instructionsToUse": "",
                "status": "not approved",
                "strength": "Stand Alone",
                "strengthSepioID": "SEPIO:0000325",
                "text": "",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Not applicable",
                "id": "0207",
                "instructionsToUse": "",
                "status": "not approved",
                "strength": "Very Strong",
                "strengthSepioID": "",
                "text": "",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Not Applicable",
                "id": "0068",
                "instructionsToUse": "",
                "status": "not approved",
                "strength": "Strong",
                "strengthSepioID": "SEPIO:0000328",
                "text": "",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Not Applicable",
                "id": "0208",
                "instructionsToUse": "",
                "status": "not approved",
                "strength": "Moderate",
                "strengthSepioID": "SEPIO:0000699",
                "text": "",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Applicable",
                "id": "118",
                "instructionsToUse": "",
                "specificationType": [
                  "Disease-specific",
                  "Gene-specific"
                ],
                "status": "approved",
                "strength": "Supporting",
                "strengthSepioID": "SEPIO:0000327",
                "text": "Other variants must be pathogenic as defined by these specifications.\n\nTesting of parents or other informative relatives is often required to determine _cis_/_trans_ status.\n\nIf a variant is seen in _trans_ (or as double heterozygous) with another pathogenic variant in ≥2 cases and the phenotype is not more severe than when either of the two variants are seen in isolation, this rule may be applied (i.e., high confidence this variant is NOT contributing to disease).\n\n*   \\<1% of cases of HCM have >1 pathogenic or likely pathogenic variant (0.6%; Alfares _et al._ 2015[<sup>17</sup>](#pmid_25611685)).\n\nThis rule cannot be applied when the variant has only been observed in _cis_ with a pathogenic variant as its significance in isolation is unknown in this scenario. \n\nCaution is needed if using this criterion as a primary piece of evidence for classifying a variant as likely benign/benign (i.e., only 2 SUPPORTING criteria are sufficient for a likely benign classification).",
                "type": "EvidenceLineStrength"
              }
            ]
          },
          "entType": "CriteriaCode",
          "ldhId": "135637782",
          "ldhIri": "https://cspec.genome.network/cspec/CriteriaCode/id/135637782",
          "modified": "2024-04-22T15:42:56.196Z",
          "modifier": "makelly2",
          "rev": "_inf5AqW--U"
        },
        {
          "entContent": {
            "_uniqueProp": "002_BS4_nuclear_MYH7",
            "additionalComments": "",
            "applicability": "Applicable",
            "baseStrength": "Benign",
            "defaultStrength": "Benign Strong",
            "disease": [
              "MONDO:0004994",
              "MONDO:0005021",
              "MONDO:0005045",
              "MONDO:0005201",
              "MONDO:0009144"
            ],
            "evidenceCategory": "Segregation Data",
            "gene": [
              "MYH7"
            ],
            "geneType": "nuclear",
            "label": "BS4",
            "ns": "002",
            "originalACMGSummary": "Lack of segregation in affected members of a family.\nCaveat: The presence of phenocopies for common phenotypes (i.e. cancer, epilepsy) can mimic lack of segregation among affected individuals. Also, families may have more than one pathogenic variant contributing to an autosomal dominant disorder, further confounding an apparent lack of segregation.",
            "sepioID": "SEPIO-CG:99042",
            "specificationType": [],
            "status": {
              "Pilot Rules In Prep": {
                "completed": true
              }
            },
            "strengthDescriptor": [
              {
                "applicability": "Not applicable",
                "id": "0229",
                "instructionsToUse": "",
                "status": "not approved",
                "strength": "Stand Alone",
                "strengthSepioID": "SEPIO:0000325",
                "text": "",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Not applicable",
                "id": "0227",
                "instructionsToUse": "",
                "status": "not approved",
                "strength": "Very Strong",
                "strengthSepioID": "",
                "text": "",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Applicable",
                "id": "121",
                "instructionsToUse": "",
                "specificationType": [
                  "Disease-specific"
                ],
                "status": "approved",
                "strength": "Strong",
                "strengthSepioID": "SEPIO:0000328",
                "text": "Any non-segregations should be carefully evaluated to rule out a phenocopy or the presence of a second disease-causing variant before considering it as conflicting or benign evidence. \n\n1.  The presence of “phenocopies” (e.g., athlete’s heart, hypertensive heart disease, ischemic cardiomyopathy, alcoholic cardiomyopathy, diabetic cardiomyopathy) can mimic non-segregation (i.e., lack of segregation) among affected individuals. \n2.  Families may have more than one pathogenic variant contributing to an autosomal dominant disorder, further confounding an apparent ‘non-segregation’.\n\nBecause of these possibilities, **multiple (≥2) non-segregations** that are highly unlikely to be phenocopies or due to alternate variants (e.g., those without a possible alternate cause) **are required to apply this rule**.  A higher number of non-segregations is necessary for instances where alternative causes are possible (e.g., non-segregation in a sibling with childhood onset cardiomyopathy versus a grandparent with hypertension and HCM).\n\nCareful consideration of the above points is required when using this data as conflicting evidence, especially when overall evidence supports likely pathogenic or pathogenic.",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Not Applicable",
                "id": "0228",
                "instructionsToUse": "",
                "status": "not approved",
                "strength": "Moderate",
                "strengthSepioID": "SEPIO:0000699",
                "text": "",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Not Applicable",
                "id": "0077",
                "instructionsToUse": "",
                "status": "not approved",
                "strength": "Supporting",
                "strengthSepioID": "SEPIO:0000327",
                "text": "",
                "type": "EvidenceLineStrength"
              }
            ]
          },
          "entType": "CriteriaCode",
          "ldhId": "135637779",
          "ldhIri": "https://cspec.genome.network/cspec/CriteriaCode/id/135637779",
          "modified": "2024-04-22T15:42:56.196Z",
          "modifier": "makelly2",
          "rev": "_inf5AqS--I"
        },
        {
          "entContent": {
            "_uniqueProp": "002_BS1_nuclear_MYH7",
            "additionalComments": "",
            "applicability": "Applicable",
            "baseStrength": "Benign",
            "defaultStrength": "Benign Strong",
            "disease": [
              "MONDO:0004994",
              "MONDO:0005021",
              "MONDO:0005045",
              "MONDO:0005201",
              "MONDO:0009144"
            ],
            "evidenceCategory": "Population Data",
            "gene": [
              "MYH7"
            ],
            "geneType": "nuclear",
            "label": "BS1",
            "ns": "002",
            "originalACMGSummary": "Allele frequency is greater than expected for disorder.",
            "sepioID": "SEPIO-CG:99039",
            "specificationType": [],
            "status": {
              "Pilot Rules In Prep": {
                "completed": true
              }
            },
            "strengthDescriptor": [
              {
                "applicability": "Not applicable",
                "id": "0090",
                "instructionsToUse": "",
                "status": "not approved",
                "strength": "Stand Alone",
                "strengthSepioID": "SEPIO:0000325",
                "text": "",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Not applicable",
                "id": "0222",
                "instructionsToUse": "",
                "status": "not approved",
                "strength": "Very Strong",
                "strengthSepioID": "",
                "text": "",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Applicable",
                "id": "120",
                "instructionsToUse": "",
                "specificationType": [
                  "Disease-specific",
                  "Gene-specific"
                ],
                "status": "approved",
                "strength": "Strong",
                "strengthSepioID": "SEPIO:0000328",
                "text": "Allele frequency is **≥0.0001 for** _**MYH7**_ based on the **filtering allele frequency (FAF)** in **gnomAD** in the subpopulation with the highest frequency (popmax).\n\nCriterion BS1 may only be used as standalone evidence to classify a variant as Likely Benign in the absence of conflicting data. See SVI guidance (Tavtigian _et al._ 2018[<sup>16</sup>](#pmid_29300386); Tavtigian _et al._ 2020[<sup>15</sup>](#pmid_32720330)). \n\nSee BA1 for additional specifications that also apply to BS1.",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Not Applicable",
                "id": "0223",
                "instructionsToUse": "",
                "status": "not approved",
                "strength": "Moderate",
                "strengthSepioID": "SEPIO:0000699",
                "text": "",
                "type": "EvidenceLineStrength"
              },
              {
                "applicability": "Not Applicable",
                "id": "0086",
                "instructionsToUse": "",
                "status": "not approved",
                "strength": "Supporting",
                "strengthSepioID": "SEPIO:0000327",
                "text": "",
                "type": "EvidenceLineStrength"
              }
            ]
          },
          "entType": "CriteriaCode",
          "ldhId": "135637772",
          "ldhIri": "https://cspec.genome.network/cspec/CriteriaCode/id/135637772",
          "modified": "2024-04-22T15:42:56.196Z",
          "modifier": "makelly2",
          "rev": "_inf5AqS--J"
        }
      ],
      "Disease": [
        {
          "entContent": {
            "MONDO": {
              "id": "http://purl.obolibrary.org/obo/MONDO_0005021",
              "lbl": "dilated cardiomyopathy",
              "meta": {
                "basicPropertyValues": [
                  {
                    "pred": "http://purl.obolibrary.org/obo/mondo#curated_content_resource",
                    "val": "https://search.clinicalgenome.org/kb/conditions/MONDO:0005021"
                  },
                  {
                    "pred": "http://purl.obolibrary.org/obo/mondo#curated_content_resource",
                    "val": "https://www.malacards.org/card/dilated_cardiomyopathy"
                  },
                  {
                    "pred": "http://www.w3.org/2004/02/skos/core#closeMatch",
                    "val": "http://identifiers.org/meddra/10056370"
                  },
                  {
                    "pred": "http://www.w3.org/2004/02/skos/core#exactMatch",
                    "val": "http://id.who.int/icd/entity/1916294688"
                  },
                  {
                    "pred": "http://www.w3.org/2004/02/skos/core#exactMatch",
                    "val": "http://identifiers.org/medgen/2880"
                  },
                  {
                    "pred": "http://www.w3.org/2004/02/skos/core#exactMatch",
                    "val": "http://identifiers.org/mesh/D002311"
                  },
                  {
                    "pred": "http://www.w3.org/2004/02/skos/core#exactMatch",
                    "val": "http://identifiers.org/snomedct/195021004"
                  },
                  {
                    "pred": "http://www.w3.org/2004/02/skos/core#exactMatch",
                    "val": "http://linkedlifedata.com/resource/umls/id/C0007193"
                  },
                  {
                    "pred": "http://www.w3.org/2004/02/skos/core#exactMatch",
                    "val": "http://purl.bioontology.org/ontology/ICD10CM/I42.0"
                  },
                  {
                    "pred": "http://www.w3.org/2004/02/skos/core#exactMatch",
                    "val": "http://purl.obolibrary.org/obo/DOID_12930"
                  },
                  {
                    "pred": "http://www.w3.org/2004/02/skos/core#exactMatch",
                    "val": "http://purl.obolibrary.org/obo/NCIT_C84673"
                  },
                  {
                    "pred": "http://www.w3.org/2004/02/skos/core#exactMatch",
                    "val": "http://www.ebi.ac.uk/efo/EFO_0000407"
                  },
                  {
                    "pred": "http://www.w3.org/2004/02/skos/core#exactMatch",
                    "val": "http://www.orpha.net/ORDO/Orphanet_217604"
                  }
                ],
                "definition": {
                  "val": "Cardiomyopathy which is characterized by dilation and contractile dysfunction of the left and right ventricles. It may be idiopathic, or it may result from a myocardial infarction, myocardial infection, or alcohol abuse. It is a cause of congestive heart failure.",
                  "xrefs": [
                    "NCIT:P378"
                  ]
                },
                "subsets": [
                  "http://purl.obolibrary.org/obo/mondo#clingen",
                  "http://purl.obolibrary.org/obo/mondo#disease_grouping",
                  "http://purl.obolibrary.org/obo/mondo#doid_rare",
                  "http://purl.obolibrary.org/obo/mondo#gard_rare",
                  "http://purl.obolibrary.org/obo/mondo#nord_rare",
                  "http://purl.obolibrary.org/obo/mondo#ordo_group_of_disorders",
                  "http://purl.obolibrary.org/obo/mondo#otar",
                  "http://purl.obolibrary.org/obo/mondo#rare"
                ],
                "synonyms": [
                  {
                    "pred": "hasExactSynonym",
                    "val": "dilated cardiomyopathy",
                    "xrefs": [
                      "DOID:12930",
                      "ICD10CM:I42.0",
                      "NCIT:C84673",
                      "Orphanet:217604",
                      "icd11.foundation:1916294688"
                    ]
                  },
                  {
                    "pred": "hasRelatedSynonym",
                    "val": "familial dilated cardiomyopathy",
                    "xrefs": [
                      "DOID:12930",
                      "MESH:C536231"
                    ]
                  },
                  {
                    "pred": "hasRelatedSynonym",
                    "val": "idiopathic dilation cardiomyopathy",
                    "xrefs": [
                      "DOID:12930",
                      "MESH:C536277"
                    ]
                  }
                ],
                "xrefs": [
                  {
                    "val": "DOID:12930"
                  },
                  {
                    "val": "EFO:0000407"
                  },
                  {
                    "val": "GARD:0000221"
                  },
                  {
                    "val": "HP:0001644"
                  },
                  {
                    "val": "ICD10CM:I42.0"
                  },
                  {
                    "val": "ICD9:425.4"
                  },
                  {
                    "val": "MEDGEN:2880"
                  },
                  {
                    "val": "MESH:D002311"
                  },
                  {
                    "val": "MedDRA:10056370"
                  },
                  {
                    "val": "NANDO:2100057"
                  },
                  {
                    "val": "NANDO:2200232"
                  },
                  {
                    "val": "NCIT:C84673"
                  },
                  {
                    "val": "Orphanet:217604"
                  },
                  {
                    "val": "SCTID:195021004"
                  },
                  {
                    "val": "UMLS:C0007193"
                  },
                  {
                    "val": "icd11.foundation:1916294688"
                  }
                ]
              },
              "type": "CLASS"
            },
            "MONDOID": "MONDO:0005021",
            "name": "dilated cardiomyopathy",
            "preferredModeOfInheritance": {
              "inheritance": "Autosomal dominant inheritance",
              "sepioID": "HP:0000006"
            }
          },
          "entId": "MONDO:0005021",
          "entIri": "http://purl.obolibrary.org/obo/MONDO_0005021",
          "entType": "Disease",
          "ldhId": "135641998",
          "ldhIri": "https://cspec.genome.network/cspec/Disease/id/135641998",
          "modified": "2026-10-17T21:31:50.115Z",
          "modifier": "cspecAdministrator",
          "rev": "_mStFMkS---"
        },
        {
          "entContent": {
            "MONDO": {
              "id": "http://purl.obolibrary.org/obo/MONDO_0005201",
              "lbl": "restrictive cardiomyopathy",
              "meta": {
                "basicPropertyValues": [
                  {
                    "pred": "http://purl.obolibrary.org/obo/mondo#curated_content_resource",
                    "val": "https://www.malacards.org/card/restrictive_cardiomyopathy"
                  },
                  {
                    "pred": "http://www.w3.org/2004/02/skos/core#closeMatch",
                    "val": "http://identifiers.org/meddra/10038748"
                  },
                  {
                    "pred": "http://www.w3.org/2004/02/skos/core#exactMatch",
                    "val": "http://id.who.int/icd/entity/316495940"
                  },
                  {
                    "pred": "http://www.w3.org/2004/02/skos/core#exactMatch",
                    "val": "http://identifiers.org/medgen/40111"
                  },
                  {
                    "pred": "http://www.w3.org/2004/02/skos/core#exactMatch",
                    "val": "http://identifiers.org/mesh/D002313"
                  },
                  {
                    "pred": "http://www.w3.org/2004/02/skos/core#exactMatch",
                    "val": "http://identifiers.org/snomedct/415295002"
                  },
                  {
                    "pred": "http://www.w3.org/2004/02/skos/core#exactMatch",
                    "val": "http://linkedlifedata.com/resource/umls/id/C0007196"
                  },
                  {
                    "pred": "http://www.w3.org/2004/02/skos/core#exactMatch",
                    "val": "http://purl.obolibrary.org/obo/DOID_397"
                  },
                  {
                    "pred": "http://www.w3.org/2004/02/skos/core#exactMatch",
                    "val": "http://purl.obolibrary.org/obo/NCIT_C62798"
                  },
                  {
                    "pred": "http://www.w3.org/2004/02/skos/core#exactMatch",
                    "val": "http://www.ebi.ac.uk/efo/EFO_0002630"
                  },
                  {
                    "pred": "http://www.w3.org/2004/02/skos/core#exactMatch",
                    "val": "http://www.orpha.net/ORDO/Orphanet_217632"
                  }
                ],
                "definition": {
                  "val": "A type of heart disorder referring to the inability of the ventricles to fill with blood because the myocardium (heart muscle) stiffens and looses its flexibility. Causes include replacement of the myocardium with scar tissue, abnormal cellular infiltration of the myocardium, or deposition of a substance (e.g., amyloid) in the myocardium.",
                  "xrefs": [
                    "NCIT:C62798"
                  ]
                },
                "subsets": [
                  "http://purl.obolibrary.org/obo/mondo#disease_grouping",
                  "http://purl.obolibrary.org/obo/mondo#doid_rare",
                  "http://purl.obolibrary.org/obo/mondo#gard_rare",
                  "http://purl.obolibrary.org/obo/mondo#nord_rare",
                  "http://purl.obolibrary.org/obo/mondo#ordo_group_of_disorders",
                  "http://purl.obolibrary.org/obo/mondo#otar",
                  "http://purl.obolibrary.org/obo/mondo#rare"
                ],
                "synonyms": [
                  {
                    "pred": "hasExactSynonym",
                    "val": "restrictive cardiomyopathy",
                    "xrefs": [
                      "DOID:397",
                      "NCIT:C62798",
                      "Orphanet:217632",
                      "icd11.foundation:316495940"
                    ]
                  },
                  {
                    "pred": "hasNarrowSynonym",
                    "val": "familial restrictive cardiomyopathy"
                  }
                ],
                "xrefs": [
                  {
                    "val": "DOID:397"
                  },
                  {
                    "val": "EFO:0002630"
                  },
                  {
                    "val": "GARD:0020531"
                  },
                  {
                    "val": "ICD9:425.4"
                  },
                  {
                    "val": "MEDGEN:40111"
                  },
                  {
                    "val": "MESH:D002313"
                  },
                  {
                    "val": "MedDRA:10038748"
                  },
                  {
                    "val": "NANDO:1200292"
                  },
                  {
                    "val": "NANDO:1200293"
                  },
                  {
                    "val": "NANDO:2100058"
                  },
                  {
                    "val": "NANDO:2200233"
                  },
                  {
                    "val": "NCIT:C62798"
                  },
                  {
                    "val": "Orphanet:217632"
                  },
                  {
                    "val": "SCTID:415295002"
                  },
                  {
                    "val": "UMLS:C0007196"
                  },
                  {
                    "val": "icd11.foundation:316495940"
                  }
                ]
              },
              "type": "CLASS"
            },
            "MONDOID": "MONDO:0005201",
            "name": "restrictive cardiomyopathy",
            "preferredModeOfInheritance": {
              "inheritance": "Autosomal dominant inheritance",
              "sepioID": "HP:0000006"
            }
          },
          "entId": "MONDO:0005201",
          "entIri": "http://purl.obolibrary.org/obo/MONDO_0005201",
          "entType": "Disease",
          "ldhId": "135641996",
          "ldhIri": "https://cspec.genome.network/cspec/Disease/id/135641996",
          "modified": "2026-10-17T21:31:52.666Z",
          "modifier": "cspecAdministrator",
          "rev": "_mStFO8m---"
        },
        {
          "entContent": {
            "MONDO": {
              "id": "http://purl.obolibrary.org/obo/MONDO_0005045",
              "lbl": "hypertrophic cardiomyopathy",
              "meta": {
                "basicPropertyValues": [
                  {
                    "pred": "http://purl.obolibrary.org/obo/IAO_0000233",
                    "val": "https://github.com/monarch-initiative/mondo/issues/5962"
                  },
                  {
                    "pred": "http://purl.obolibrary.org/obo/mondo#curated_content_resource",
                    "val": "https://search.clinicalgenome.org/kb/conditions/MONDO:0005045"
                  },
                  {
                    "pred": "http://purl.obolibrary.org/obo/mondo#curated_content_resource",
                    "val": "https://www.malacards.org/card/hypertrophic_cardiomyopathy"
                  },
                  {
                    "pred": "http://purl.obolibrary.org/obo/mondo#curated_content_resource",
                    "val": "https://www.malacards.org/card/rare_hypertrophic_cardiomyopathy"
                  },
                  {
                    "pred": "http://www.w3.org/2004/02/skos/core#closeMatch",
                    "val": "http://identifiers.org/meddra/10020871"
                  },
                  {
                    "pred": "http://www.w3.org/2004/02/skos/core#exactMatch",
                    "val": "http://id.who.int/icd/entity/1830681485"
                  },
                  {
                    "pred": "http://www.w3.org/2004/02/skos/core#exactMatch",
                    "val": "http://identifiers.org/medgen/2881"
                  },
                  {
                    "pred": "http://www.w3.org/2004/02/skos/core#exactMatch",
                    "val": "http://identifiers.org/mesh/D002312"
                  },
                  {
                    "pred": "http://www.w3.org/2004/02/skos/core#exactMatch",
                    "val": "http://identifiers.org/snomedct/233873004"
                  },
                  {
                    "pred": "http://www.w3.org/2004/02/skos/core#exactMatch",
                    "val": "http://linkedlifedata.com/resource/umls/id/C0007194"
                  },
                  {
                    "pred": "http://www.w3.org/2004/02/skos/core#exactMatch",
                    "val": "http://purl.obolibrary.org/obo/DOID_11984"
                  },
                  {
                    "pred": "http://www.w3.org/2004/02/skos/core#exactMatch",
                    "val": "http://purl.obolibrary.org/obo/NCIT_C34449"
                  },
                  {
                    "pred": "http://www.w3.org/2004/02/skos/core#exactMatch",
                    "val": "http://www.ebi.ac.uk/efo/EFO_0000538"
                  },
                  {
                    "pred": "http://www.w3.org/2004/02/skos/core#exactMatch",
                    "val": "http://www.orpha.net/ORDO/Orphanet_217569"
                  },
                  {
                    "pred": "http://www.w3.org/2004/02/skos/core#narrowMatch",
                    "val": "http://purl.bioontology.org/ontology/ICD10CM/I42.1"
                  },
                  {
                    "pred": "http://www.w3.org/2004/02/skos/core#relatedMatch",
                    "val": "http://purl.bioontology.org/ontology/ICD10CM/I42.2"
                  }
                ],
                "definition": {
                  "val": "A condition in which the myocardium is hypertrophied without an obvious cause. The hypertrophy is generally asymmetric and may be associated with obstruction of the ventricular outflow tract.",
                  "xrefs": [
                    "NCIT:C34449"
                  ]
                },
                "subsets": [
                  "http://purl.obolibrary.org/obo/mondo#clingen",
                  "http://purl.obolibrary.org/obo/mondo#disease_grouping",
                  "http://purl.obolibrary.org/obo/mondo#doid_rare",
                  "http://purl.obolibrary.org/obo/mondo#inferred_rare",
                  "http://purl.obolibrary.org/obo/mondo#ordo_group_of_disorders",
                  "http://purl.obolibrary.org/obo/mondo#otar",
                  "http://purl.obolibrary.org/obo/mondo#rare"
                ],
                "synonyms": [
                  {
                    "pred": "hasExactSynonym",
                    "val": "hypertrophic cardiomyopathy",
                    "xrefs": [
                      "DOID:11984",
                      "NCIT:C34449",
                      "icd11.foundation:1830681485"
                    ]
                  },
                  {
                    "pred": "hasExactSynonym",
                    "val": "hypertrophic subaortic stenosis"
                  },
                  {
                    "pred": "hasExactSynonym",
                    "val": "obstructive hypertrophic cardiomyopathy"
                  },
                  {
                    "pred": "hasNarrowSynonym",
                    "val": "familial hypertrophic cardiomyopathy"
                  }
                ],
                "xrefs": [
                  {
                    "val": "DOID:11984"
                  },
                  {
                    "val": "EFO:0000538"
                  },
                  {
                    "val": "HP:0001639"
                  },
                  {
                    "val": "ICD10CM:I42.1"
                  },
                  {
                    "val": "ICD10CM:I42.2"
                  },
                  {
                    "val": "ICD9:425.1"
                  },
                  {
                    "val": "ICD9:425.11"
                  },
                  {
                    "val": "ICD9:425.4"
                  },
                  {
                    "val": "MEDGEN:2881"
                  },
                  {
                    "val": "MESH:D002312"
                  },
                  {
                    "val": "MedDRA:10020871"
                  },
                  {
                    "val": "NANDO:1200286"
                  },
                  {
                    "val": "NANDO:1200288"
                  },
                  {
                    "val": "NANDO:2100054"
                  },
                  {
                    "val": "NANDO:2200229"
                  },
                  {
                    "val": "NANDO:2201042"
                  },
                  {
                    "val": "NCIT:C34449"
                  },
                  {
                    "val": "Orphanet:217569"
                  },
                  {
                    "val": "SCTID:233873004"
                  },
                  {
                    "val": "UMLS:C0007194"
                  },
                  {
                    "val": "icd11.foundation:1830681485"
                  }
                ]
              },
              "type": "CLASS"
            },
            "MONDOID": "MONDO:0005045",
            "name": "hypertrophic cardiomyopathy",
            "preferredModeOfInheritance": {
              "inheritance": "Autosomal dominant inheritance",
              "sepioID": "HP:0000006"
            }
          },
          "entId": "MONDO:0005045",
          "entIri": "http://purl.obolibrary.org/obo/MONDO_0005045",
          "entType": "Disease",
          "ldhId": "135641999",
          "ldhIri": "https://cspec.genome.network/cspec/Disease/id/135641999",
          "modified": "2026-10-17T21:31:50.115Z",
          "modifier": "cspecAdministrator",
          "rev": "_mStFMsa---"
        },
        {
          "entContent": {
            "MONDO": {
              "id": "http://purl.obolibrary.org/obo/MONDO_0004994",
              "lbl": "cardiomyopathy",
              "meta": {
                "basicPropertyValues": [
                  {
                    "pred": "http://purl.obolibrary.org/obo/mondo#curated_content_resource",
                    "val": "https://www.malacards.org/card/rare_cardiomyopathy"
                  },
                  {
                    "pred": "http://www.w3.org/2004/02/skos/core#closeMatch",
                    "val": "http://identifiers.org/meddra/10007636"
                  },
                  {
                    "pred": "http://www.w3.org/2004/02/skos/core#exactMatch",
                    "val": "http://id.who.int/icd/entity/282225286"
                  },
                  {
                    "pred": "http://www.w3.org/2004/02/skos/core#exactMatch",
                    "val": "http://identifiers.org/medgen/209232"
                  },
                  {
                    "pred": "http://www.w3.org/2004/02/skos/core#exactMatch",
                    "val": "http://identifiers.org/mesh/D009202"
                  },
                  {
                    "pred": "http://www.w3.org/2004/02/skos/core#exactMatch",
                    "val": "http://identifiers.org/snomedct/85898001"
                  },
                  {
                    "pred": "http://www.w3.org/2004/02/skos/core#exactMatch",
                    "val": "http://linkedlifedata.com/resource/umls/id/C0878544"
                  },
                  {
                    "pred": "http://www.w3.org/2004/02/skos/core#exactMatch",
                    "val": "http://purl.bioontology.org/ontology/ICD10CM/I42"
                  },
                  {
                    "pred": "http://www.w3.org/2004/02/skos/core#exactMatch",
                    "val": "http://purl.obolibrary.org/obo/DOID_0050700"
                  },
                  {
                    "pred": "http://www.w3.org/2004/02/skos/core#exactMatch",
                    "val": "http://purl.obolibrary.org/obo/NCIT_C34830"
                  },
                  {
                    "pred": "http://www.w3.org/2004/02/skos/core#exactMatch",
                    "val": "http://www.ebi.ac.uk/efo/EFO_0000318"
                  },
                  {
                    "pred": "http://www.w3.org/2004/02/skos/core#exactMatch",
                    "val": "http://www.orpha.net/ORDO/Orphanet_167848"
                  },
                  {
                    "pred": "http://www.w3.org/2004/02/skos/core#exactMatch",
                    "val": "https://icd.who.int/browse10/2019/en#/I42"
                  }
                ],
                "definition": {
                  "val": "A disease of the heart muscle or myocardium proper. Cardiomyopathies may be classified as either primary or secondary, on the basis of etiology, or on the pathophysiology of the lesion: hypertrophic, dilated, or restrictive.",
                  "xrefs": [
                    "NCIT:C34830"
                  ]
                },
                "subsets": [
                  "http://purl.obolibrary.org/obo/mondo#disease_grouping",
                  "http://purl.obolibrary.org/obo/mondo#ordo_group_of_disorders",
                  "http://purl.obolibrary.org/obo/mondo#otar"
                ],
                "synonyms": [
                  {
                    "pred": "hasExactSynonym",
                    "val": "Cardiomyopathies",
                    "xrefs": [
                      "DOID:0050700",
                      "MESH:D009202"
                    ]
                  },
                  {
                    "pred": "hasExactSynonym",
                    "val": "cardiomyopathy",
                    "xrefs": [
                      "DOID:0050700",
                      "ICD10CM:I42",
                      "ICD10WHO:I42",
                      "MONDO:0015670",
                      "NCIT:C34830",
                      "icd11.foundation:282225286"
                    ]
                  }
                ],
                "xrefs": [
                  {
                    "val": "DOID:0050700"
                  },
                  {
                    "val": "EFO:0000318"
                  },
                  {
                    "val": "ICD10CM:I42"
                  },
                  {
                    "val": "ICD10WHO:I42"
                  },
                  {
                    "val": "ICD9:425"
                  },
                  {
                    "val": "ICD9:425.4"
                  },
                  {
                    "val": "ICD9:425.9"
                  },
                  {
                    "val": "MEDGEN:209232"
                  },
                  {
                    "val": "MESH:D009202"
                  },
                  {
                    "val": "MedDRA:10007636"
                  },
                  {
                    "val": "NCIT:C34830"
                  },
                  {
                    "val": "Orphanet:167848"
                  },
                  {
                    "val": "SCTID:85898001"
                  },
                  {
                    "val": "UMLS:C0878544"
                  },
                  {
                    "val": "icd11.foundation:282225286"
                  }
                ]
              },
              "type": "CLASS"
            },
            "MONDOID": "MONDO:0004994",
            "name": "cardiomyopathy",
            "preferredModeOfInheritance": {
              "inheritance": "Autosomal dominant inheritance",
              "sepioID": "HP:0000006"
            }
          },
          "entId": "MONDO:0004994",
          "entIri": "http://purl.obolibrary.org/obo/MONDO_0004994",
          "entType": "Disease",
          "ldhId": "135641997",
          "ldhIri": "https://cspec.genome.network/cspec/Disease/id/135641997",
          "modified": "2026-10-17T21:31:48.649Z",
          "modifier": "cspecAdministrator",
          "rev": "_mStFLgy---"
        },
        {
          "entContent": {
            "MONDO": {
              "id": "http://purl.obolibrary.org/obo/MONDO_0009144",
              "lbl": "Ebstein anomaly",
              "meta": {
                "basicPropertyValues": [
                  {
                    "pred": "http://purl.obolibrary.org/obo/IAO_0000233",
                    "val": "https://github.com/monarch-initiative/mondo/issues/9097"
                  },
                  {
                    "pred": "http://purl.obolibrary.org/obo/IAO_0000589",
                    "val": "Ebstein anomaly (disease)"
                  },
                  {
                    "pred": "http://purl.obolibrary.org/obo/mondo#curated_content_resource",
                    "val": "https://www.malacards.org/card/ebstein_anomaly"
                  },
                  {
                    "pred": "http://purl.obolibrary.org/obo/mondo#excluded_subClassOf",
                    "val": "http://purl.obolibrary.org/obo/MONDO_0005561"
                  },
                  {
                    "pred": "http://purl.obolibrary.org/obo/mondo#excluded_subClassOf",
                    "val": "http://purl.obolibrary.org/obo/MONDO_0018797"
                  },
                  {
                    "pred": "http://www.w3.org/2004/02/skos/core#closeMatch",
                    "val": "http://identifiers.org/meddra/10014075"
                  },
                  {
                    "pred": "http://www.w3.org/2004/02/skos/core#exactMatch",
                    "val": "http://id.who.int/icd/entity/307157712"
                  },
                  {
                    "pred": "http://www.w3.org/2004/02/skos/core#exactMatch",
                    "val": "http://identifiers.org/medgen/4435"
                  },
                  {
                    "pred": "http://www.w3.org/2004/02/skos/core#exactMatch",
                    "val": "http://identifiers.org/mesh/D004437"
                  },
                  {
                    "pred": "http://www.w3.org/2004/02/skos/core#exactMatch",
                    "val": "http://linkedlifedata.com/resource/umls/id/C0013481"
                  },
                  {
                    "pred": "http://www.w3.org/2004/02/skos/core#exactMatch",
                    "val": "http://purl.bioontology.org/ontology/ICD10CM/Q22.5"
                  },
                  {
                    "pred": "http://www.w3.org/2004/02/skos/core#exactMatch",
                    "val": "http://purl.obolibrary.org/obo/DOID_14289"
                  },
                  {
                    "pred": "http://www.w3.org/2004/02/skos/core#exactMatch",
                    "val": "http://purl.obolibrary.org/obo/NCIT_C84681"
                  },
                  {
                    "pred": "http://www.w3.org/2004/02/skos/core#exactMatch",
                    "val": "http://www.ebi.ac.uk/efo/EFO_0007244"
                  },
                  {
                    "pred": "http://www.w3.org/2004/02/skos/core#exactMatch",
                    "val": "http://www.orpha.net/ORDO/Orphanet_1880"
                  },
                  {
                    "pred": "http://www.w3.org/2004/02/skos/core#exactMatch",
                    "val": "https://omim.org/entry/224700"
                  }
                ],
                "definition": {
                  "val": "Ebstein's malformation is a rare congenital cardiac anomaly characterized by rotational displacement of the septal and inferior leaflets of the tricuspid valve such that they are hinged within the right ventricle, rather than as expected at the atrioventricular junction.",
                  "xrefs": [
                    "Orphanet:1880"
                  ]
                },
                "subsets": [
                  "http://purl.obolibrary.org/obo/mondo#doid_rare",
                  "http://purl.obolibrary.org/obo/mondo#gard_rare",
                  "http://purl.obolibrary.org/obo/mondo#ncit_rare",
                  "http://purl.obolibrary.org/obo/mondo#nord_rare",
                  "http://purl.obolibrary.org/obo/mondo#ordo_disorder",
                  "http://purl.obolibrary.org/obo/mondo#ordo_morphological_anomaly",
                  "http://purl.obolibrary.org/obo/mondo#orphanet_rare",
                  "http://purl.obolibrary.org/obo/mondo#otar",
                  "http://purl.obolibrary.org/obo/mondo#rare"
                ],
                "synonyms": [
                  {
                    "pred": "hasExactSynonym",
                    "val": "Ebstein anomaly",
                    "xrefs": [
                      "DOID:14289",
                      "NCIT:C84681",
                      "OMIM:224700",
                      "icd11.foundation:307157712"
                    ]
                  },
                  {
                    "pred": "hasExactSynonym",
                    "val": "Ebstein anomaly (disease)",
                    "xrefs": [
                      "https://orcid.org/0000-0002-6601-2165"
                    ]
                  },
                  {
                    "pred": "hasExactSynonym",
                    "val": "Ebstein anomaly of the tricuspid valve",
                    "xrefs": [
                      "Orphanet:1880"
                    ]
                  },
                  {
                    "pred": "hasExactSynonym",
                    "val": "Ebstein's anomaly",
                    "xrefs": [
                      "DOID:14289",
                      "ICD10CM:Q22.5",
                      "ICD9CM:746.2",
                      "NCIT:C84681"
                    ]
                  },
                  {
                    "pred": "hasExactSynonym",
                    "val": "Ebstein's anomaly (disorder) [ambiguous]"
                  },
                  {
                    "pred": "hasExactSynonym",
                    "val": "Ebstein's anomaly of tricuspid valve",
                    "xrefs": [
                      "DOID:14289",
                      "NCIT:C84681"
                    ]
                  },
                  {
                    "pred": "hasRelatedSynonym",
                    "val": "Ebstein's malformation",
                    "xrefs": [
                      "GARD:0006313"
                    ]
                  }
                ],
                "xrefs": [
                  {
                    "val": "DOID:14289"
                  },
                  {
                    "val": "EFO:0007244"
                  },
                  {
                    "val": "GARD:0006313"
                  },
                  {
                    "val": "ICD10CM:Q22.5"
                  },
                  {
                    "val": "ICD9:746.2"
                  },
                  {
                    "val": "MEDGEN:4435"
                  },
                  {
                    "val": "MESH:D004437"
                  },
                  {
                    "val": "MedDRA:10014075"
                  },
                  {
                    "val": "NANDO:1200711"
                  },
                  {
                    "val": "NANDO:2100080"
                  },
                  {
                    "val": "NANDO:2200260"
                  },
                  {
                    "val": "NCIT:C84681"
                  },
                  {
                    "val": "OMIM:224700"
                  },
                  {
                    "val": "Orphanet:1880"
                  },
                  {
                    "val": "UMLS:C0013481"
                  },
                  {
                    "val": "icd11.foundation:307157712"
                  }
                ]
              },
              "type": "CLASS"
            },
            "MONDOID": "MONDO:0009144",
            "name": "Ebstein anomaly",
            "preferredModeOfInheritance": {
              "inheritance": "Autosomal dominant inheritance",
              "sepioID": "HP:0000006"
            }
          },
          "entId": "MONDO:0009144",
          "entIri": "http://purl.obolibrary.org/obo/MONDO_0009144",
          "entType": "Disease",
          "ldhId": "135642000",
          "ldhIri": "https://cspec.genome.network/cspec/Disease/id/135642000",
          "modified": "2026-10-17T21:32:44.318Z",
          "modifier": "cspecAdministrator",
          "rev": "_mStGBnK---"
        }
      ],
      "EvidenceCategory": [
        {
          "entContent": {
            "label": "Other Data",
            "sepioId": ""
          },
          "entType": "EvidenceCategory",
          "ldhId": "135642490",
          "ldhIri": "https://cspec.genome.network/cspec/EvidenceCategory/id/135642490",
          "modified": null,
          "rev": "_inf5Asm--r"
        },
        {
          "entContent": {
            "label": "Segregation Data",
            "sepioId": ""
          },
          "entType": "EvidenceCategory",
          "ldhId": "135642485",
          "ldhIri": "https://cspec.genome.network/cspec/EvidenceCategory/id/135642485",
          "modified": null,
          "rev": "_inf5Asi---"
        },
        {
          "entContent": {
            "label": "De novo Data",
            "sepioId": ""
          },
          "entType": "EvidenceCategory",
          "ldhId": "135642492",
          "ldhIri": "https://cspec.genome.network/cspec/EvidenceCategory/id/135642492",
          "modified": null,
          "rev": "_inf5Asm--t"
        },
        {
          "entContent": {
            "label": "Population Data",
            "sepioId": ""
          },
          "entType": "EvidenceCategory",
          "ldhId": "135642486",
          "ldhIri": "https://cspec.genome.network/cspec/EvidenceCategory/id/135642486",
          "modified": null,
          "rev": "_inf5AsS--_"
        },
        {
          "entContent": {
            "label": "Allelic Data",
            "sepioId": ""
          },
          "entType": "EvidenceCategory",
          "ldhId": "135642488",
          "ldhIri": "https://cspec.genome.network/cspec/EvidenceCategory/id/135642488",
          "modified": null,
          "rev": "_inf5Asi--A"
        },
        {
          "entContent": {
            "label": "Functional Data",
            "sepioId": ""
          },
          "entType": "EvidenceCategory",
          "ldhId": "135642491",
          "ldhIri": "https://cspec.genome.network/cspec/EvidenceCategory/id/135642491",
          "modified": null,
          "rev": "_inf5Asi--B"
        },
        {
          "entContent": {
            "label": "Other Database",
            "sepioId": ""
          },
          "entType": "EvidenceCategory",
          "ldhId": "135642489",
          "ldhIri": "https://cspec.genome.network/cspec/EvidenceCategory/id/135642489",
          "modified": null,
          "rev": "_inf5Asm--o"
        },
        {
          "entContent": {
            "label": "Computational And Predictive Data",
            "sepioId": ""
          },
          "entType": "EvidenceCategory",
          "ldhId": "135642487",
          "ldhIri": "https://cspec.genome.network/cspec/EvidenceCategory/id/135642487",
          "modified": null,
          "rev": "_inf5Asi--_"
        }
      ],
      "Gene": [
        {
          "entContent": {
            "HGNC": {
              "_version_": 1704056955071365000,
              "agr": "HGNC:7577",
              "alias_symbol": [
                "CMD1S"
              ],
              "ccds_id": [
                "CCDS9601"
              ],
              "date_approved_reserved": "1986-01-01",
              "date_modified": "2021-05-26",
              "date_name_changed": "2016-06-22",
              "ena": [
                "M58018"
              ],
              "ensembl_gene_id": "ENSG00000092054",
              "entrez_id": "4625",
              "gene_group": [
                "Myosin heavy chains, class II",
                "MicroRNA protein coding host genes"
              ],
              "gene_group_id": [
                1098,
                1691
              ],
              "hgnc_id": "HGNC:7577",
              "location": "14q11.2",
              "location_sortable": "14q11.2",
              "locus_group": "protein-coding gene",
              "locus_type": "gene with protein product",
              "lsdb": [
                "FHC Mutation Database|http://www.angis.org.au/Databases/Heart/heartbreak.html",
                "LRG_384|http://ftp.ebi.ac.uk/pub/databases/lrgex/LRG_384.xml"
              ],
              "mane_select": [
                "ENST00000355349.4",
                "NM_000257.4"
              ],
              "mgd_id": [
                "MGI:2155600"
              ],
              "name": "myosin heavy chain 7",
              "omim_id": [
                "160760"
              ],
              "orphanet": 123621,
              "prev_name": [
                "myopathy, distal 1",
                "myosin, heavy polypeptide 7, cardiac muscle, beta"
              ],
              "prev_symbol": [
                "CMH1",
                "MPD1"
              ],
              "pubmed_id": [
                2494889,
                8483915,
                15322983
              ],
              "refseq_accession": [
                "NM_000257"
              ],
              "rgd_id": [
                "RGD:62030"
              ],
              "status": "Approved",
              "symbol": "MYH7",
              "symbol_report_tag": [
                "Stable symbol"
              ],
              "ucsc_id": "uc001wjx.4",
              "uniprot_ids": [
                "P12883"
              ],
              "uuid": "6a9c6657-136d-48c3-be6c-5a823ad924b8",
              "vega_id": "OTTHUMG00000028755"
            },
            "NCBI": {
              "id": "4625"
            }
          },
          "entId": "MYH7",
          "entIri": "https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:7577",
          "entType": "Gene",
          "ldhId": "135641799",
          "ldhIri": "https://cspec.genome.network/cspec/Gene/id/135641799",
          "modified": "2021-10-14T11:36:27.781Z",
          "modifier": "genbadmin",
          "rev": "_inf5A8---D"
        }
      ],
      "RuleSet": [
        {
          "entContent": {
            "_uniqueProp": "002_nuclear_MYH7",
            "geneType": "nuclear",
            "genes": [
              {
                "diseases": [
                  {
                    "preferredModeOfInheritance": "Autosomal dominant inheritance",
                    "preferredMondoId": "MONDO:0005021",
                    "preferredTitle": "dilated cardiomyopathy"
                  },
                  {
                    "preferredModeOfInheritance": "Autosomal dominant inheritance",
                    "preferredMondoId": "MONDO:0005045",
                    "preferredTitle": "hypertrophic cardiomyopathy"
                  }
                ],
                "gene": "MYH7"
              }
            ],
            "ns": "002",
            "references": [
              {
                "auths": [
                  "Richards S",
                  "Aziz N",
                  "et al."
                ],
                "doiStr": "10.1038/gim.2015.30",
                "id": "25741868",
                "iss": "(5)",
                "namespace": "pmid",
                "pages": "p. 405-24.",
                "source": "Genet Med",
                "title": "Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.",
                "vol": "17",
                "year": "2015"
              },
              {
                "id": "c73e109e-b916-5a72-b7b1-1762446f3c11",
                "namespace": "url",
                "value": "https://clinicalgenome.org/working-groups/sequence-variant-interpretation/"
              },
              {
                "auths": [
                  "Abou Tayoun AN",
                  "Pesaran T",
                  "et al."
                ],
                "doiStr": "10.1002/humu.23626",
                "id": "30192042",
                "iss": "(11)",
                "namespace": "pmid",
                "pages": "p. 1517-1524.",
                "source": "Hum Mutat",
                "title": "Recommendations for interpreting the loss of function PVS1 ACMG/AMP variant criterion.",
                "vol": "39",
                "year": "2018"
              },
              {
                "auths": [
                  "Brnich SE",
                  "Abou Tayoun AN",
                  "et al."
                ],
                "doiStr": "10.1186/s13073-019-0690-2",
                "id": "31892348",
                "iss": "(1)",
                "namespace": "pmid",
                "pages": "p. 3.",
                "source": "Genome Med",
                "title": "Recommendations for application of the functional evidence PS3/BS3 criterion using the ACMG/AMP sequence variant interpretation framework.",
                "vol": "12",
                "year": "2019"
              },
              {
                "auths": [
                  "Hershberger RE",
                  "Morales A",
                  "et al."
                ],
                "doiStr": "10.1161/CIRCGENETICS.117.001968",
                "id": "29212902",
                "iss": "(6)",
                "namespace": "pmid",
                "pages": "",
                "source": "Circ Cardiovasc Genet",
                "title": "Is Left Ventricular Noncompaction a Trait, Phenotype, or Disease? The Evidence Points to Phenotype.",
                "vol": "10",
                "year": "2017"
              },
              {
                "auths": [
                  "Oechslin E",
                  "Jenni R"
                ],
                "doiStr": "10.1016/j.cjca.2017.04.003",
                "id": "28545618",
                "iss": "(6)",
                "namespace": "pmid",
                "pages": "p. 701-704.",
                "source": "Can J Cardiol",
                "title": "Nosology of Noncompaction Cardiomyopathy: The Emperor Still Wears Clothes!",
                "vol": "33",
                "year": "2017"
              },
              {
                "auths": [
                  "Ross SB",
                  "Jones K",
                  "et al."
                ],
                "doiStr": "10.1093/eurheartj/ehz317",
                "id": "31143950",
                "iss": "(14)",
                "namespace": "pmid",
                "pages": "p. 1428-1436.",
                "source": "Eur Heart J",
                "title": "A systematic review and meta-analysis of the prevalence of left ventricular non-compaction in adults.",
                "vol": "41",
                "year": "2020"
              },
              {
                "auths": [
                  "Walsh R",
                  "Thomson KL",
                  "et al."
                ],
                "doiStr": "10.1038/gim.2016.90",
                "id": "27532257",
                "iss": "(2)",
                "namespace": "pmid",
                "pages": "p. 192-203.",
                "source": "Genet Med",
                "title": "Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples.",
                "vol": "19",
                "year": "2017"
              },
              {
                "auths": [
                  "Anderson RH",
                  "Jensen B",
                  "et al."
                ],
                "doiStr": "10.1016/j.cjca.2017.01.017",
                "id": "28395867",
                "iss": "(6)",
                "namespace": "pmid",
                "pages": "p. 747-757.",
                "source": "Can J Cardiol",
                "title": "Key Questions Relating to Left Ventricular Noncompaction Cardiomyopathy: Is the Emperor Still Wearing Any Clothes?",
                "vol": "33",
                "year": "2017"
              },
              {
                "auths": [
                  "Walsh R",
                  "Mazzarotto F",
                  "et al."
                ],
                "doiStr": "10.1186/s13073-019-0616-z",
                "id": "30696458",
                "iss": "(1)",
                "namespace": "pmid",
                "pages": "p. 5.",
                "source": "Genome Med",
                "title": "Quantitative approaches to variant classification increase the yield and precision of genetic testing in Mendelian diseases: the case of hypertrophic cardiomyopathy.",
                "vol": "11",
                "year": "2019"
              },
              {
                "auths": [
                  "Kelly MA",
                  "Caleshu C",
                  "et al."
                ],
                "doiStr": "10.1038/gim.2017.218",
                "id": "29300372",
                "iss": "(3)",
                "namespace": "pmid",
                "pages": "p. 351-359.",
                "source": "Genet Med",
                "title": "Adaptation and validation of the ACMG/AMP variant classification framework for MYH7-associated inherited cardiomyopathies: recommendations by ClinGen's Inherited Cardiomyopathy Expert Panel.",
                "vol": "20",
                "year": "2018"
              },
              {
                "auths": [
                  "Jarvik GP",
                  "Browning BL"
                ],
                "doiStr": "10.1016/j.ajhg.2016.04.003",
                "id": "27236918",
                "iss": "(6)",
                "namespace": "pmid",
                "pages": "p. 1077-1081.",
                "source": "Am J Hum Genet",
                "title": "Consideration of Cosegregation in the Pathogenicity Classification of Genomic Variants.",
                "vol": "98",
                "year": "2016"
              },
              {
                "auths": [
                  "Jaganathan K",
                  "Kyriazopoulou Panagiotopoulou S",
                  "et al."
                ],
                "doiStr": "10.1016/j.cell.2018.12.015",
                "id": "30661751",
                "iss": "(3)",
                "namespace": "pmid",
                "pages": "p. 535-548.e24.",
                "source": "Cell",
                "title": "Predicting Splicing from Primary Sequence with Deep Learning.",
                "vol": "176",
                "year": "2019"
              },
              {
                "auths": [
                  "Ioannidis NM",
                  "Rothstein JH",
                  "et al."
                ],
                "doiStr": "10.1016/j.ajhg.2016.08.016",
                "id": "27666373",
                "iss": "(4)",
                "namespace": "pmid",
                "pages": "p. 877-885.",
                "source": "Am J Hum Genet",
                "title": "REVEL: An Ensemble Method for Predicting the Pathogenicity of Rare Missense Variants.",
                "vol": "99",
                "year": "2016"
              },
              {
                "auths": [
                  "Tavtigian SV",
                  "Harrison SM",
                  "et al."
                ],
                "doiStr": "10.1002/humu.24088",
                "id": "32720330",
                "iss": "(10)",
                "namespace": "pmid",
                "pages": "p. 1734-1737.",
                "source": "Hum Mutat",
                "title": "Fitting a naturally scaled point system to the ACMG/AMP variant classification guidelines.",
                "vol": "41",
                "year": "2020"
              },
              {
                "auths": [
                  "Tavtigian SV",
                  "Greenblatt MS",
                  "et al."
                ],
                "doiStr": "10.1038/gim.2017.210",
                "id": "29300386",
                "iss": "(9)",
                "namespace": "pmid",
                "pages": "p. 1054-1060.",
                "source": "Genet Med",
                "title": "Modeling the ACMG/AMP variant classification guidelines as a Bayesian classification framework.",
                "vol": "20",
                "year": "2018"
              },
              {
                "auths": [
                  "Alfares AA",
                  "Kelly MA",
                  "et al."
                ],
                "doiStr": "10.1038/gim.2014.205",
                "id": "25611685",
                "iss": "(11)",
                "namespace": "pmid",
                "pages": "p. 880-8.",
                "source": "Genet Med",
                "title": "Results of clinical genetic testing of 2,912 probands with hypertrophic cardiomyopathy: expanded panels offer limited additional sensitivity.",
                "vol": "17",
                "year": "2015"
              }
            ],
            "rules": {
              "mainRules": [
                {
                  "conditions": [
                    {
                      "applicableCriteriaCodes": [
                        "PS1",
                        "PS2",
                        "PS3",
                        "PS4",
                        "PP1_Strong"
                      ],
                      "condition": ">=2",
                      "label": "Rule5, Condition1",
                      "partitionPath": "Pathogenic.Strong"
                    }
                  ],
                  "inference": "Pathogenic",
                  "rule": "Rule5"
                },
                {
                  "conditions": [
                    {
                      "applicableCriteriaCodes": [
                        "PS1",
                        "PS2",
                        "PS3",
                        "PS4",
                        "PP1_Strong"
                      ],
                      "condition": "==1",
                      "label": "Rule6, Condition1",
                      "partitionPath": "Pathogenic.Strong"
                    },
                    {
                      "applicableCriteriaCodes": [
                        "PS3_Moderate",
                        "PS4_Moderate",
                        "PM1",
                        "PM4",
                        "PM5",
                        "PM6",
                        "PP1_Moderate"
                      ],
                      "condition": ">=3",
                      "label": "Rule6, Condition2",
                      "partitionPath": "Pathogenic.Moderate"
                    }
                  ],
                  "inference": "Pathogenic",
                  "rule": "Rule6"
                },
                {
                  "conditions": [
                    {
                      "applicableCriteriaCodes": [
                        "PS1",
                        "PS2",
                        "PS3",
                        "PS4",
                        "PP1_Strong"
                      ],
                      "condition": "==1",
                      "label": "Rule7, Condition1",
                      "partitionPath": "Pathogenic.Strong"
                    },
                    {
                      "applicableCriteriaCodes": [
                        "PS3_Moderate",
                        "PS4_Moderate",
                        "PM1",
                        "PM4",
                        "PM5",
                        "PM6",
                        "PP1_Moderate"
                      ],
                      "condition": "==2",
                      "label": "Rule7, Condition2",
                      "partitionPath": "Pathogenic.Moderate"
                    },
                    {
                      "applicableCriteriaCodes": [
                        "PS3_Supporting",
                        "PS4_Supporting",
                        "PM2_Supporting",
                        "PM5_Supporting",
                        "PP1",
                        "PP3"
                      ],
                      "condition": ">=2",
                      "label": "Rule7, Condition3",
                      "partitionPath": "Pathogenic.Supporting"
                    }
                  ],
                  "inference": "Pathogenic",
                  "rule": "Rule7"
                },
                {
                  "conditions": [
                    {
                      "applicableCriteriaCodes": [
                        "PS1",
                        "PS2",
                        "PS3",
                        "PS4",
                        "PP1_Strong"
                      ],
                      "condition": "==1",
                      "label": "Rule8, Condition1",
                      "partitionPath": "Pathogenic.Strong"
                    },
                    {
                      "applicableCriteriaCodes": [
                        "PS3_Moderate",
                        "PS4_Moderate",
                        "PM1",
                        "PM4",
                        "PM5",
                        "PM6",
                        "PP1_Moderate"
                      ],
                      "condition": "==1",
                      "label": "Rule8, Condition2",
                      "partitionPath": "Pathogenic.Moderate"
                    },
                    {
                      "applicableCriteriaCodes": [
                        "PS3_Supporting",
                        "PS4_Supporting",
                        "PM2_Supporting",
                        "PM5_Supporting",
                        "PP1",
                        "PP3"
                      ],
                      "condition": ">=4",
                      "label": "Rule8, Condition3",
                      "partitionPath": "Pathogenic.Supporting"
                    }
                  ],
                  "inference": "Pathogenic",
                  "rule": "Rule8"
                },
                {
                  "conditions": [
                    {
                      "applicableCriteriaCodes": [
                        "PS1",
                        "PS2",
                        "PS3",
                        "PS4",
                        "PP1_Strong"
                      ],
                      "condition": "==1",
                      "label": "Rule11, Condition1",
                      "partitionPath": "Pathogenic.Strong"
                    },
                    {
                      "applicableCriteriaCodes": [
                        "PS3_Moderate",
                        "PS4_Moderate",
                        "PM1",
                        "PM4",
                        "PM5",
                        "PM6",
                        "PP1_Moderate"
                      ],
                      "condition": "==1",
                      "label": "Rule11, Condition2",
                      "partitionPath": "Pathogenic.Moderate"
                    }
                  ],
                  "inference": "Likely Pathogenic",
                  "rule": "Rule11"
                },
                {
                  "conditions": [
                    {
                      "applicableCriteriaCodes": [
                        "PS1",
                        "PS2",
                        "PS3",
                        "PS4",
                        "PP1_Strong"
                      ],
                      "condition": "==1",
                      "label": "Rule12, Condition1",
                      "partitionPath": "Pathogenic.Strong"
                    },
                    {
                      "applicableCriteriaCodes": [
                        "PS3_Supporting",
                        "PS4_Supporting",
                        "PM2_Supporting",
                        "PM5_Supporting",
                        "PP1",
                        "PP3"
                      ],
                      "condition": ">=2",
                      "label": "Rule12, Condition2",
                      "partitionPath": "Pathogenic.Supporting"
                    }
                  ],
                  "inference": "Likely Pathogenic",
                  "rule": "Rule12"
                },
                {
                  "conditions": [
                    {
                      "applicableCriteriaCodes": [
                        "PS3_Moderate",
                        "PS4_Moderate",
                        "PM1",
                        "PM4",
                        "PM5",
                        "PM6",
                        "PP1_Moderate"
                      ],
                      "condition": ">=3",
                      "label": "Rule13, Condition1",
                      "partitionPath": "Pathogenic.Moderate"
                    }
                  ],
                  "inference": "Likely Pathogenic",
                  "rule": "Rule13"
                },
                {
                  "conditions": [
                    {
                      "applicableCriteriaCodes": [
                        "PS3_Moderate",
                        "PS4_Moderate",
                        "PM1",
                        "PM4",
                        "PM5",
                        "PM6",
                        "PP1_Moderate"
                      ],
                      "condition": "==2",
                      "label": "Rule14, Condition1",
                      "partitionPath": "Pathogenic.Moderate"
                    },
                    {
                      "applicableCriteriaCodes": [
                        "PS3_Supporting",
                        "PS4_Supporting",
                        "PM2_Supporting",
                        "PM5_Supporting",
                        "PP1",
                        "PP3"
                      ],
                      "condition": ">=2",
                      "label": "Rule14, Condition2",
                      "partitionPath": "Pathogenic.Supporting"
                    }
                  ],
                  "inference": "Likely Pathogenic",
                  "rule": "Rule14"
                },
                {
                  "conditions": [
                    {
                      "applicableCriteriaCodes": [
                        "PS3_Moderate",
                        "PS4_Moderate",
                        "PM1",
                        "PM4",
                        "PM5",
                        "PM6",
                        "PP1_Moderate"
                      ],
                      "condition": "==1",
                      "label": "Rule15, Condition1",
                      "partitionPath": "Pathogenic.Moderate"
                    },
                    {
                      "applicableCriteriaCodes": [
                        "PS3_Supporting",
                        "PS4_Supporting",
                        "PM2_Supporting",
                        "PM5_Supporting",
                        "PP1",
                        "PP3"
                      ],
                      "condition": ">=4",
                      "label": "Rule15, Condition2",
                      "partitionPath": "Pathogenic.Supporting"
                    }
                  ],
                  "inference": "Likely Pathogenic",
                  "rule": "Rule15"
                },
                {
                  "conditions": [
                    {
                      "applicableCriteriaCodes": [
                        "PS1",
                        "PS2",
                        "PS3",
                        "PS4",
                        "PP1_Strong"
                      ],
                      "condition": "==1",
                      "label": "Rule20, Condition1",
                      "partitionPath": "Pathogenic.Strong"
                    },
                    {
                      "applicableCriteriaCodes": [
                        "PS3_Moderate",
                        "PS4_Moderate",
                        "PM1",
                        "PM4",
                        "PM5",
                        "PM6",
                        "PP1_Moderate"
                      ],
                      "condition": "==2",
                      "label": "Rule20, Condition2",
                      "partitionPath": "Pathogenic.Moderate"
                    }
                  ],
                  "inference": "Likely Pathogenic",
                  "rule": "Rule20"
                },
                {
                  "conditions": [
                    {
                      "applicableCriteriaCodes": [
                        "BS1",
                        "BS3",
                        "BS4"
                      ],
                      "condition": ">=2",
                      "label": "Rule16, Condition1",
                      "partitionPath": "Benign.Strong"
                    }
                  ],
                  "inference": "Benign",
                  "rule": "Rule16"
                },
                {
                  "conditions": [
                    {
                      "applicableCriteriaCodes": [
                        "BA1"
                      ],
                      "condition": "==1",
                      "label": "Rule17, Condition1",
                      "partitionPath": "Benign.Stand Alone"
                    }
                  ],
                  "inference": "Benign",
                  "rule": "Rule17"
                },
                {
                  "conditions": [
                    {
                      "applicableCriteriaCodes": [
                        "BS1",
                        "BS3",
                        "BS4"
                      ],
                      "condition": "==1",
                      "label": "Rule18, Condition1",
                      "partitionPath": "Benign.Strong"
                    },
                    {
                      "applicableCriteriaCodes": [
                        "BS3_Supporting",
                        "BP2",
                        "BP4",
                        "BP7"
                      ],
                      "condition": "==1",
                      "label": "Rule18, Condition2",
                      "partitionPath": "Benign.Supporting"
                    }
                  ],
                  "inference": "Likely Benign",
                  "rule": "Rule18"
                },
                {
                  "conditions": [
                    {
                      "applicableCriteriaCodes": [
                        "BS3_Supporting",
                        "BP2",
                        "BP4",
                        "BP7"
                      ],
                      "condition": ">=2",
                      "label": "Rule19, Condition1",
                      "partitionPath": "Benign.Supporting"
                    }
                  ],
                  "inference": "Likely Benign",
                  "rule": "Rule19"
                }
              ]
            }
          },
          "entType": "RuleSet",
          "ldhId": "135640453",
          "ldhIri": "https://cspec.genome.network/cspec/RuleSet/id/135640453",
          "modified": "2024-04-22T15:42:56.094Z",
          "modifier": "makelly2",
          "rev": "_inf5BHe--i"
        }
      ]
    },
    "ldFor": {
      "Organization": [
        {
          "entContent": {
            "approval": {
              "step1": {
                "approved": true
              },
              "step2": {
                "approved": true
              },
              "step3": {
                "approved": true
              },
              "step4": {
                "approvalDate": "2017-04-29T00:00:00.000Z",
                "approved": true
              }
            },
            "curationActivity": "Variant Pathogenicity",
            "fullBaseName": "Cardiomyopathy",
            "shortBaseName": "CMP",
            "shortTitle": "Cardiomyopathy VCEP",
            "title": "Cardiomyopathy Variant Curation Expert Panel",
            "type": "Variant Curation Expert Panel"
          },
          "entId": "50002",
          "entIri": "http://clinicalgenome.org/affiliation/50002",
          "entType": "Organization",
          "ldhId": "135637627",
          "ldhIri": "https://cspec.genome.network/cspec/Organization/id/135637627",
          "modified": "2023-04-07T14:55:06.014Z",
          "modifier": "cspecAdministrator",
          "rev": "_inf5B-2---"
        }
      ],
      "SequenceVariantInterpretation": [
        {
          "entContent": {
            "approvedOn": "03-05-2015",
            "description": "ACMG ISV guidelines 2015",
            "namespace": "GN001",
            "notes": "",
            "references": [
              {
                "source": "PubMed",
                "url": "https://pubmed.ncbi.nlm.nih.gov/25741868"
              }
            ],
            "shortTitle": "ACMG 2015-Guidelines",
            "specificationSource": "https://www.acmg.net/docs/Standards_Guidelines_for_the_Interpretation_of_Sequence_Variants.pdf",
            "tagNameSpaces": [
              "001"
            ],
            "title": "Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology",
            "version": "1.0.0"
          },
          "entId": "GN001",
          "entType": "SequenceVariantInterpretation",
          "ldhId": "135637585",
          "ldhIri": "https://cspec.genome.network/cspec/SequenceVariantInterpretation/id/135637585",
          "modified": "2022-08-18T15:51:43.074Z",
          "modifier": "cspecAdministrator",
          "rev": "_inf5BXe---"
        }
      ]
    },
    "ldhId": "135637574",
    "ldhIri": "https://cspec.genome.network/cspec/SequenceVariantInterpretation/id/135637574",
    "modified": "2026-07-20T17:44:16.929Z",
    "modifier": "cspecAdministrator",
    "rev": "_l2Ae4Qu---"
  },
  "metadata": {
    "rendered": {
      "by": "https://cspec.genome.network/cspec/srvc",
      "when": "2026-11-19T07:42:26.757Z"
    }
  },
  "status": {
    "code": 200,
    "name": "OK"
  }
}